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Abstract: 
Objective: There is, however, much debate within the research community as to the role 
of psychological factors in predicting or influencing disease outcome in breast cancer.  
Previous reviews have investigated the role of psychological factors in studies with 
extremely heterogeneous samples making it difficult to generalise findings.  This present 
review therefore tried to address this criticism by focusing on studies only including 
participants with early stage breast cancer.  The aim was to summarise the evidence for 
an association between psychological responses and the risk of recurrence and/or survival 
outcome in this population.   
Method: A systematic search was performed using the Ovid MEDLINE, EMBASE and 
PsychoINFO databases to identify relevant studies.  Sixteen studies were identified which 
met inclusion criteria.  Criteria assessing methodological quality were applied using a 
specifically designed checklist, which resulted in a methodological quality rating being 
calculated for each study.   
Results: From the sixteen studies identified only three were rated as ‘high’ quality and 
the majority were of ‘moderate’ quality.  The findings of the review indicated that there 
are contradictory findings in the literature for the main psychological factors investigated.  
The methodological flaws that are inherent within the literature are highlighted.   
Conclusions:  As yet there is not sufficient evidence for any psychological factor to 
conclude that it significantly contributes to the progression of cancer.  There are however 
too many studies with significant findings to conclude that these psychological factors are 
of no importance at all.  There is a need for further and more rigorously designed 
research and so future research directions are discussed. 
Keywords: breast cancer, psychological factors, progression, survival, systematic review.
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Introduction 
Breast cancer is the most common cancer diagnosed in women in Scotland and a 
significant cause of morbidity and mortality(1;2).  The number of people being diagnosed 
with breast cancer each year continues to rise, mainly due to the life expectancy 
increasing and an aging population(1;3).  There has, however, been a noted improvement 
in breast cancer survival, with a 39% decrease in death rates from breast cancer observed 
between 1989 and 2008 (2). This in the main is due to improvements in screening and 
treatment(1;2).  These improvements have resulted in an interest in the quality of life and 
psychological wellbeing of survivors of breast cancer.  A study by Dean(4) found that 
one in four women experienced significant psychological symptoms twelve months after 
mastectomy.  The most common difficulties were depression, anxiety and sexual 
dysfunction(4).  In the literature there is evidence and general consensus that 
psychological interventions do improve psychological wellbeing in cancer survivors(5).  
In the development of this field the question has been raised as to whether psychological 
factors can play a role in the progression of disease.  A psychological intervention study 
with individuals with advanced breast cancer initially gave weight to this claim(6).  It 
demonstrated that after 10 years' follow up participants who received therapy had lived 
twice as long as those patients in the control group (37 months compared with 19 
months)(6).  The study, however, had some methodological problems and these findings 
have not been consistently replicated in other similar studies(7). 
 
There are opposing views in the literature regarding the influence of psychological 
factors on the progression of cancer and long-term survival for breast cancer patients.  
The claim that psychological factors may influence disease progression is of great interest 
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to cancer patients.  Some researchers have expressed their concern regarding the potential 
harm for patients, who may put themselves under undue pressure to employ a particular 
coping style or response, which is not their normal coping style, to improve the outcome 
of their disease(8).  There is evidence that those individuals who attribute the diagnosis of 
cancer to psychological factors are more distressed and less hopeful than other 
patients(8).  There has been a large body of research investigating the role of various 
psychological factors across cancer types but there is no consensus.  There are a number 
of mechanisms that have been postulated.  Previous research has investigated the possible 
mechanisms that may influence the relationship between psychological factors and cancer 
progression.  It has been suggested that this relationship could be mediated through 
behavioural factors such as poor adherence regarding medical advice or more directly 
through biological correlates of certain emotional states.  For example, Levy and 
colleagues found that the level of NK cell activity appeared to predict the chance of later 
recurrence in successfully treated breast cancer patients(9). 
 
Whether psychological factors affect the course of cancer has important implications, 
both for the role of psychological screening and treatment of cancer patients, and for the 
progression of research.  If an individual’s psychological response to their breast cancer 
diagnosis did affect their prognosis then appropriate psychosocial interventions could be 
developed which might improve survival after breast cancer.  Conversely, if no such 
effect exists, women’s concerns could be allayed and this burden of responsibility lifted.  
Several methodological problems have contributed to the uncertainty surrounding the role 
of psychological factors and survival outcomes in cancer.  One problem is that some 
studies include participants with advanced stage cancer.  It is likely that the role of 
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psychological factors may be extremely difficult to detect in these individuals and it also 
results in heterogeneous groups, which makes it difficult to draw firm conclusions and 
generalise findings.  Therefore this systematic review will focus on breast cancer patients 
with early stage disease and no evidence of metastasis.  It seeks to determine whether 
methodological factors contribute to the variance in the findings regarding the association 
between psychological factors and recurrence or survival in this population group.  
 
Objective  
The present systematic review will summarise the literature, bearing in mind the 
methodological rigour of the studies retrieved when considering their findings.  It will 
aim to answer the following question:  
 
 What is the evidence for an association between psychological factors in response to 
a diagnosis of cancer and recurrence or survival rates in primary early stage breast 
cancer? 
 
Method 
Search Strategy 
A systematic literature search was carried out using the OVID online interface to access 
the PsychINFO (1967-2010), MEDLINE (1950 – 2010) and EMBASE (1980-2010) 
databases (See Figure 1).  Limits were set on search terms to include ‘English language’ 
and ‘human’.  
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The following search terms were used:  
1. [breast cancer] OR [breast neoplasm] OR [breast tumour] OR [breast tumor] 
2. [survival] OR [mortality] OR [death] OR [recurrence] OR [progression] 
3. [depression] OR [anxiety] OR [psychological factors] OR [psychosocial factors] OR 
[psychological coping] OR [coping behaviour] OR [emotional responses] 
 
The results of these searches were then combined using the Boolean operator ‘AND’.  
Table 1 provides a flow diagram of the search strategy.  The search identified one 
hundred and sixty-four journal articles potentially suitable for inclusion.  The following 
inclusion and exclusion criterion was then applied:   
 
Inclusion Criteria  
1. Studies that include a breast cancer population. 
2. Design is prospective. 
3. Studies which include the measurement of psychological variables as predictive 
variables of disease recurrence or survival outcome. 
4. Studies published in a peer-reviewed journal article.  
 
Exclusion Criteria  
1. Studies including heterogeneous cancer sites, without separate analysis for breast 
cancer. 
2. Studies in which the stage of cancer at diagnosis or at the commencement of the study 
was identified as metastatic for participants within the sample. 
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3. Studies only investigating psychosocial factors, such as social support as a predictor 
of survival or recurrence. 
4. Studies which include psychological variables but not as predictive variables of 
disease recurrence or survival outcome. 
5. Studies only focusing on the association between psychological factors and the 
development of breast cancer. 
6. Studies evaluating psychological interventions for psychological variables, which 
may impact on disease progression or survival outcome. 
7. Studies using a retrospective design. 
8. Review articles, single case studies, dissertations or qualitative studies. 
9. Articles summarizing findings about the association between psychological variables 
and survival as part of their study but which have been reported in other articles in 
more detail.  
 
Given the above criterion, fifty-five articles were excluded on title alone, mainly due to 
being surgical or pharmacological studies.  Of the remaining one hundred and nine, a 
further ninety-one articles were excluded based on their abstract as they did not fulfil the 
specified inclusion and exclusion criteria.  This left a full article search of the remaining 
eighteen studies, which were read in their entirety, of which eight were excluded for the 
reasons specified in Table 1. 
 
Further to this the reference sections of the articles included and the reference section of 
review articles identified from the literature search were reviewed to identify additional 
articles.  An additional six articles were identified, which met review inclusion criteria 
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and had not been generated by the electronic search.  This resulted in a total of 16 articles 
for review. 
 
[Insert Table 1 around here] 
 
Methodological Appraisal of Included Studies 
A methodological appraisal of the articles was applied to all 16 studies according to the 
criteria in Appendix 1.2.  The scoring system was based on the Scottish Intercollegiate 
Guidelines Network guidelines for assessing the quality of cohort studies with additional 
items that were specific to outcome studies in this area.  There was a total of 13 items and 
studies were awarded a score 2 if the criterion was met, 1 if it was partly met and 0 if the 
criterion was not met or it was not possible to determine from the information given.  
Therefore, each paper was given a rating out of 26, with higher scores indicating superior 
methods. Papers that met 75% of the methodological criterion specified were considered 
to be of ‘high’ quality.  Papers that rated between 50% and 75% were deemed to have a 
‘moderate’ quality rating and those studies that achieved less the 50% quality rating were 
considered to be of ‘lower’ quality.   
 
Reliability of quality rating  
To assess the reliability of this tool, a second reviewer using the same tool rated 7 of the 
final 16 papers.  These included papers of high, medium and low methodological quality.  
Overall percentage agreement was high (>95%). Discrepancies in ratings were resolved 
by the author and independent rater meeting to discuss and review disagreements. 
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Results 
Review of Findings  
The sixteen studies included in the review ranged in sample size from 40 to 708 
participants. No studies included male participants.  Nine of the sixteen studies 
investigate depression, seven examine anxiety, eleven explore psychological response or 
coping and five examine emotional control.  A further six studies also investigate general 
psychological distress.  Table 2 provides details of study design, sample characteristics, 
psychological variables measured, disease outcome and main findings.  Studies will be 
reviewed in order of quality rating.  Overall three studies were of ‘high’ quality, eleven 
were ‘moderate’ quality and two were of ‘low’ methodological quality.  
 
[Insert Table 2 around here]
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High Quality 
These three studies investigated different psychological factors. 
Barraclough and colleagues(10) was rated as the highest methodological quality study 
and examined the effect of psychosocial stress on cancer recurrence. The experience of a 
depressive illness was assessed as an adverse life event and findings indicated that it was 
associated with a shorter time to disease recurrence.  Despite being of particularly high 
methodological quality, the relationship between depression and recurrence was not the 
main focus of the study.  Symptoms of major depression were assessed in interview, 
using American Psychiatric Association’s Diagnostic and Statistical Manual of Mental 
Disorders – 3rd Edition (DSM-III).  Only 45 of 204 participants met criteria.  It is also 
important to note that the follow up period was only three and half years. 
 
Watson and colleagues(11) examined the association between breast cancer survival and 
recurrence with a number of psychological factors measured at two time points (see 
Table 2).  Although this was one of the three highly rated methodological studies there 
were a number of limitations noted.  Survival was recorded as death from all causes 
rather than as a result of cancer recurrence and there were a significant number of 
statistical tests completed so increasing the risk of a Type 1 error.  A high score on the 
depression scale of the Hospital Anxiety and Depression Scale (HADS) was associated 
with increased risk of death but not recurrence; however, only 2% of the sample met 
‘caseness’ for depression.   Response to cancer was analysed in two forms; firstly by 
recording one ‘predominant response’ as assessed by the Mental Adjustment to Cancer 
Scale (MAC), which did not result in any significant associations being found.  The 
second form of analysis dichotomised each scale at the standard cut-off score so an 
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individual was categorised as being high or low on each type of response.  This indicated 
a significant association between the helplessness and hopelessness category and event 
free survival only (see Table 2).         
 
Goodwin and colleagues(12) examined the effects of reduced health-related quality of 
life and psychologic factors on breast cancer survival and recurrence (see Table 2).  
Although categorised as a high quality study there were a number of limitations 
identified.  Approximately half of the sample was followed up for less than five years and 
they only classified distant metastatic cancer as recurrence.  Baseline measures were 
returned by post so the range of time from diagnosis to return of questionnaires was 0.5 
week to 36 weeks, which resulted in individuals being assessed at significantly different 
stages in treatment.  Some of the participants assessed immediately after diagnosis would 
have been going through normal adjustment and may not have experienced significant 
psychological distress.  They did however complete a follow up assessment a year later 
but which again were returned over a protracted period (42-76 weeks).  A strength of the 
study was that it considered the issue of power, however they variables which had 80% 
power to detect hazard ratios were in the main for total scores of measures used rather 
than individual subscales. 
 
Moderate Quality 
The 11 studies rated as ‘moderate’ quality investigated a range of psychological 
variables.  The most frequently investigated psychological factor was coping or 
psychological response to a diagnosis of cancer, although a range of measures were used 
to examine the type of response.  Studies are therefore critiqued by summarising the 
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studies which did not find a significant association and then those that did for recurrence 
and/or survival.  In each section the study rated with the highest score for methodological 
criteria is reported first.  The results for the other psychological factors assessed in each 
study are also discussed.  Four studies did not find a significant association between 
coping response and outcome as defined by survival or recurrence. 
 
Buddeberg and colleagues(13) investigated the effect of different coping strategies on 
breast cancer survival using two questionnaires as can be seen in Table 2.  It did not find 
a significant relationship between coping response and survival.  The measures employed 
in this study were not used in any of the other included studies.  This article has a number 
of strengths in terms of its design, particularly including multiple assessments of coping 
over the follow-up period.  This indicated firstly that the form of coping employed 
changed over time and secondly that numerous coping strategies could be employed at 
any one time point.  A significant methodological flaw, however, was that as a result of a 
reduced sample size over time there was only adequate power to detect large effect sizes.  
 
Cousson-Gélie and colleagues(14)  investigated the role of anxiety and coping strategies 
(see Table 2).   They did not find a significant association between the type of coping 
strategy employed and outcome. The tool used to assess coping was not used in other 
studies apart from one, which used a different version of the scale and included different 
categories.  They did however find a significant association between survival and 
anxiety; low anxiety scores being associated with shorter survival times.  The authors 
postulated that low anxiety scores indicated the absence or controlled expression of 
negative effect and questioned if there was a role for the restriction of emotions but this 
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was not assessed.  Although this study has a number of strengths it did not include 
repeated measures of coping and anxiety and the psychological variables were assessed 
three weeks after diagnosis.  Psychological factors assessed during the first month, may 
be capturing a normal reaction to being informed of a diagnosis of a life-threatening 
illness, rather than the onset of a clinically significant problem that may affect outcome.  
 
A study by Phillips and colleagues(15) assessing social support and psychological factors 
(see Table 2) found a significant association between the coping response ‘anxious 
preoccupation’ and disease recurrence and overall survival.  This effect however, was 
only found in the analysis which was not adjusted for biological and treatment factors.  
The authors postulated that the association between ‘anxious preoccupation’ and outcome 
was due to anxious preoccupation being correlated with poor prognostic factors such as 
age and grade of tumour, rather than being directly associated with a poorer prognosis.  
This study had a number of limitations such as there being a wide range in the time from 
diagnosis until assessment of psychological factors.  The authors however tried to address 
this by taking it into consideration during the analysis of the results.  The other significant 
drawbacks are that assessment of psychological measures only happened at one time 
point and it was not clear if survival rates were all cause or cancer specific.  The study 
did not find an association with depression or anxiety as measured by the HADS.  The 
variation in time at assessment may impact on these findings but probably more 
significant is the low level of symptomatology reported by the sample, particularly for 
depression (only 3% scoring above the cut-off point of 10 for ‘caseness’). 
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A study by Butow and colleagues(16) assessed psychological factors in relation to 
survival time.  It did not find a significant association for coping response or 
psychological adjustment but used assessment tools not used by other studies.  It did find 
a significant association between two aspects of cognitive appraisal of threat (see Table 
2).  This was a sub-scale selected from a validated tool and had not been used by any of 
the other studies.  The main limitations were that psychological responses were only 
assessed at one time point and the follow up period would have benefitted from being 
longer.   
 
Five studies did find a significant association between coping response and outcome. 
The study by Osborne and colleagues(17) was rated as medium quality and assessed the 
role of immune factors and psychosocial factors in survival from early breast cancer (see 
Table 2).  It was one of two studies which tried to examine a possible biological 
mediating role, which meant as a result psychological measurements were assessed only 
at one time point.  There was a significant association found for a fighting spirit – 
minimising the illness but no significant association found for anxiety or depression.  
Unfortunately, there are limitations to this study, as the time of assessment from 
diagnosis varied considerably between participants ranging from five to seventeen 
months.  Also a small sample size and multiple comparisons meant that the study only 
had sufficient power to detect large hazard ratios. 
 
Lehto and colleagues(18) examined a large number of psychological and psychosocial 
variables (see Table 2).  The study found a significant effect for individuals using a 
distancing response and behavioural escape avoidance, using a standardised measure.  
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They also found a significant association for emotional defensiveness and depression (see 
Table 2).  Depression was assessed using a screening tool assessing feelings and 
symptoms experienced during the previous month.  This was not used by any of the other 
included studies.  Overall, although there were a number of methodological strengths to 
this article a significant limitation was that assessment of psychological factors was made 
at only one time point.  There were also a large number of variables included in the 
analysis and the issue of power was not addressed.   
 
An early study by Greer and colleagues(19) investigated the association of a number of 
psychological responses to breast cancer and outcome.  As a result of being an earlier 
study response to cancer was assessed by interview and the predominant response was 
rated independently by two observers rather than by a standardised tool, which is an 
obvious limitation.  Although there was a number of time points, analysis only included 
variables measured at baseline and at 3 months and coping response was only assessed at 
one time point.  Analysis did not include the Cox proportional hazards regression model 
which allows analysis of time to event.  Analysis found recurrence free survival 
significantly more common among individuals with denial or fighting spirit responses 
than stoic acceptance as assessed at three months.  There were no significant associations 
for the other variables assessed.  Depression which is commonly investigated in other 
studies was assessed using the Hamilton Rating Scale (HRS).  The range of scores for the 
depression measure is not reported so it is unclear if the scores were skewed.  Another 
obvious limitation is the small sample size particularly due to the reduction in the sample 
size at three months.    
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Dean and colleagues(20) examined the relationship between general health and a number 
of psychological factors assessed at two time points (see Table 2) and survival and cancer 
recurrence.  Although this study found an association for particular coping responses (see 
Table 2) a major limitation is that individuals were categorised at each time point as 
exhibiting a predominant response as assessed by interview and rated by the interviewer, 
rather than using a standardised measure.  Depression and anxiety was assessed using 
research diagnostic criteria, which may result in significantly different results compared 
to the use of self-report measures.  The results showed that meeting diagnostic criteria 
pre-operatively resulted in an association with recurrence but this was not evident when 
measured post-operatively.  For neither time point was there an association with survival.  
These findings are in opposition to those reported by Barraclough and colleagues(10).  
 
Morris and colleagues(21) examined the effect of psychological response on survival and 
recurrence at 3 years after diagnosis and 5 years later.   Fighting spirit or denial responses 
tend to have better prognosis than stoic acceptance or a helpless/hopeless response (see 
Table 2).  Depression scores did not distinguish between those who died or not at five 
year follow up. Although this study found a significant association between 
psychological response and outcome, psychological response was elicited by interview.  
Although the authors made efforts to rate the predominant psychological response only 
88 of the 107 participants could be categorized.  The five categories had to be collapsed 
as a result of small numbers within each category, for example only four participants 
were characterized as using the hopeless/helpless response.  A strength however was that 
it did assess psychological responses at a number of time points.   
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Two of the eleven studies did not investigate the role of coping: 
The study by Tross and colleagues (22) specifically investigated if the degree of 
psychological symptoms present in response to a diagnosis of breast cancer was 
associated with recurrence and/or overall survival.  The use of a general measure of 
psychological distress versus a more specific psychological construct is unlikely to be 
significantly associated with outcome data.  Further to this the data was trichotomized 
and only 12.5% of the sample was included in the top category with symptom levels at or 
above the cut-off for psychiatric casesness.  Other limitations to the study are that it only 
measured psychological responses at one time point, only all cause mortality was 
reported and the analysis did not include the use of the Cox proportional hazards 
regression model. 
 
The study by Kreitler and colleagues(23) used a general measure of psychological 
distress and did find a significant association but this was not as strong as other 
psychosocial factors assessed.  Using a validated tool to assess anxiety it did find lower 
anxiety scores were associated with better health at three years but not five years.  Unlike 
the study by Cousson-Gélie and colleagues(14) anxiety was not associated with survival.  
The studies used the same measure to assess anxiety so this difference may have been 
due to the timing of assessment or the length of follow-up. There was a significant 
amount of variance in the timing of assessment for this study. 
 
Low Quality  
 The two studies rated as low quality only investigated general distress levels and 
psychological adjustment in association with outcome data.  While the study by Levy and 
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colleagues(9) found an association between lower Profile of Mood States (POMS) scores 
at follow-up and longer disease-free survival there were several limitations.  These 
included assessment of psychological factors at baseline occurring five days after 
surgery.  Strengths of the study however, were that assessment was carried out at three 
time points and that although a general measure of distress was selected; this was 
assessed using a standardised tool.  The last article reported by Gilbar(24) was rated as 
being of the lowest methodological quality.  Stepwise backward logistic regression 
analysis found evidence for high anxiety being associated with the development of 
metastasis and anxiety and somatisation predicting length of survival.  The most 
significant limitations of this study were the small sample size, assessment of 
psychological factors only two weeks after surgery and only at this time point.  Also well 
established medical and biological predictive variables were not recorded.  A strength of 
the paper was that it followed participants up for a significant length of time.    
 
Discussion 
This literature review focused on studies investigating early stage breast cancer so as to 
provide a more homogenous sample.  It was hoped that it would illuminate further the 
role of psychological factors in this particular group.  It is difficult however to draw firm 
conclusions about the association between psychological factors in general or even 
specific psychological constructs and long term outcomes regarding cancer recurrence 
and survival.  The reason for this is that a relationship identified in one study is not 
systemically confirmed in other studies and in fact there are often contradictory findings 
as evidenced in this review.   
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There were eleven studies investigating psychological response or coping.  There was no 
association found in four of the studies, which often employed less commonly used 
assessment measures.  One of these studies however did use the MAC, which is 
frequently used.  Three found a significant association and another observed a trend for 
positive coping responses to increase survival and/or time to recurrence.  These responses 
included denial, fighting spirit and distancing post-operatively and stoic or 
hopeless/helpless responses pre-operatively.   The remaining four studies found responses 
categorised as hopeless/helpless, behavioural-escape avoidance and anxious 
preoccupation were associated with poorer outcomes.  
 
There were nine studies in this review investigating depression.  Five found no 
association with cancer recurrence or survival; two found an association which indicated 
a positive effect on recurrence only; one study was associated with poorer survival only 
and in the final study depression was associated with poorer survival outcomes and 
increased risk of recurrence.  For anxiety four of the seven studies found no association.  
One study found a positive effect of anxiety assessed pre-operatively on disease 
recurrence.  The remaining two found a negative effect of anxiety on outcome.  Six 
studies explored the relationship between general psychological distress and outcome 
measures.  Three found no association and the other three found higher distress resulted 
in poorer outcomes.  Lastly emotional control was assessed by five studies; four did not 
find an association and one using a different assessment tool found emotional 
defensiveness was associated with shorter overall survival. 
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The findings of this review highlight the many methodological flaws that are inherent 
within the literature investigating the association between psychological factors and 
disease progression for early stage breast cancer.  As yet there is not sufficient evidence 
for any psychological factor to conclude that it significantly contribute to the progression 
of cancer.  There are however too many studies with significant findings to conclude that 
these psychological factors are of no importance at all.  The main methodological flaws 
that were highlighted in numerous studies were the timing and frequency of 
psychological assessments and studies being too small and under-powered to calculate 
anything other than large effect sizes.  In earlier papers there were many studies using 
interviews to assess psychological factors rather than reliable and validated tools.  This 
has been less of a problem in more recent papers, reflecting the development of 
psychological assessment tools in this area.     
 
Implications for Future Research 
These methodological difficulties limit the generalizability of findings and their ability to 
influence clinical practice.  If particular psychological factors were identified as 
important for disease progression in early stage breast cancer then these could be 
screened for in clinical practice and appropriate interventions could be developed.  The 
following recommendations based on this review may be helpful to consider when 
designing future studies in this area:   
 
 Psychological factors should be measured and analyzed at multiple time-points.  If 
the limits of the study do not allow multiple time-points then assessment should not 
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occur with the first month.  Assessments completed at this time may only assess a 
normal reaction to being informed about a diagnosis of cancer rather than the onset of 
a clinically significant problem that may affect health behaviours and outcomes.  
 Whenever possible, cancer-specific mortality should be reported separately from all-
cause mortality to draw conclusions about the direct impact of psychological factors 
on the progression of cancer specifically. 
 If there is an association between psychological factors and outcome it would be 
beneficial to investigate possible mediating links.  Although a biological mediating 
link is plausible, there is little evidence in breast cancer populations currently (9;17).   
 The literature however would benefit from a refinement of the range of tools being 
used to assess a particular psychological factor.  This would allow findings to be 
compared and generalised as a variety of instruments of different levels of validity 
and reliability have been employed.   
 
Strengths & limitations of the present review 
The systematic literature search indicated that this was the first systematic review to 
focus on the association between psychological variables and survival or recurrence 
outcome for first occurrence early breast-stage cancer.  This resulted in the exclusion of 
heterogeneous samples and studies’ investigating psychological responses after 
recurrence has occurred.  Other reviews have focused on studies assessing psychological 
responses with mixed cancer types making it difficult to draw conclusions about 
psychological factors because of the variance in biological and medical predictive 
variables across cancer sites which influence outcome.    
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The present review however has a number of limitations.  Firstly, the review was limited 
to the evaluation of results in published articles, which may result in a publication bias.  
Secondly, the methodological quality of studies was assessed using a structured rating 
scale designed especially for this review.  No previously published checklist was found to 
meet the requirements of the review.  Whilst quality ratings were completed by an 
independent rater and a high level of agreement was reached, there may be limitations in 
the design of the checklist which could have introduced bias into the ratings.  Further to 
this the methodological quality was not rated for all the studies by an independent rater.  
It is also worth noting that the review has included studies that vary in the number and 
type of variables being included for investigation.  Between and within studies continual 
and dichotomised data were utilised.  The methodological criteria did not address this.   
Another possible limitation of the study that has to be considered is that the 
methodological criteria awarded higher scores to studies that made adjustments for 
biomedical variables that are known to be predictive for disease outcome.  It however 
may be possible that psychological factors interact with biomedical factors.  For example, 
life events were related to recurrence in females with breast cancer, in the presence of 
receptors for oestrogen and/or progesterone but this relationship was not evident in 
participants with receptor negative breast cancer(25). 
 
 
Conclusion 
The aim of the present review was to summarise the evidence for an association between 
psychological responses to early stage breast cancer and the risk of recurrence and/or 
 28 
survival outcome.  Some tentative evidence has been found for there being a possible 
association between psychological responses but there is also research that refutes these 
claims.  The varied methodologies undertaken in the studies make it difficult to draw 
comparisons between studies.  Better controlled studies with larger sample sizes are 
needed before recommendations can be made with confidence.  If associations between 
psychological factors and survival are evident after utilising more rigorous methodology 
this will allow clinicians to identify individuals at risk and focus interventions on the 
possible mechanisms identified. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 29 
Reference List 
 
(1) Scottish Government. Better Cancer Care, An Action Plan, Edinburgh: Scottish  
Government; 2008. 
 
(2) http://info.cancerresearchuk.org/cancerstats/types/breast/incidence/index.htm  
(accessed 20
th
 June 2010) 
 
(3) Cancer Scenarios www.scotland.gov.uk/bettercancercare (accessed 20th June  
2010)  
 
(4) Dean C.  Psychiatric morbidity following mastectomy: preoperative predictors  
and type of illness.  J Psychosom Res 1987; 31:385-392.  
 
(5) Osborn RL, Demoncada AC, Feuerstein M.  Psychosocial Interventions for  
Depression, Anxiety and Quality of Life in Cancer Survivors: Meta-Analyses.   
Int J Psychiat Med 2006; 36(1):13-34.   
 
(6) Spiegel D, Kraemer HC, Bloom JR, Gottheil E.  Effect of psychosocial treatment  
on survival of patients with metastatic breast cancer.  Lancet 1989; 2:888-891.   
 
(7) Falagas ME, Zarkadoulia EA, Ioannidou EN, Peppas G, Christodoulou C, Rafailidis  
PI. The effect of psychosocial factors on breast cancer outcome: A systematic review.  
Breast Cancer Res 2007 Jul 17; 9(4):1-23. 
 30 
 
(8) Garssen B.  Psychological Factors and Cancer Development: Evidence after 30  
years of research. Clin Psych Review 2004; 24:315-338.   
 
(9) Levy SM, Herberman RB, Lippman M, D'Angelo T, Lee J. Immunological and  
psychosocial predictors of disease recurrence in patients with early-stage breast cancer.  
Beh Med 1991; 17(2):67-75. 
 
(10) Barraclough J, Osmond C, Taylor I, Perry M, Collins P. Life events and breast  
cancer prognosis. BMJ 1993; 307:325.    
 
(11) Watson M, Haviland JS, Greer S, Davidson J, Bliss JM: Influence of psychological  
response on survival in breast cancer: a population-based cohort study. Lancet 1999;  
354:1331-1336.   
 
(12) Goodwin PJ, Ennis M, Bordeleau LJ, Pritchard KI, Trudeau ME, Koo J, Hood N.  
Health-related quality of life and psychosocial status in breast cancer prognosis: analysis  
of multiple variables. J Clin Oncol 2004; 22:4184-4192. 
 
(13) Buddeberg C, Sieber M, Wolf C, Landolt-Ritter C. Are coping strategies related  
to disease outcome in early breast cancer? J Psychosom Res 1996;40[3]:255-264.  
 
(14) Cousson-Gelie F, Bruchon-Schweitzer M, Dilhuydy JM, Jutand MA. Do anxiety,  
body image, social support and coping strategies predict survival in breast cancer? A ten- 
 31 
year follow-up study.  Psychosom: J Consultation Liaison Psychiat 2007; 48[3]:211-216.  
 
(15) Phillips K-A, Osborne RH, Giles GG, et al.  Psychosocial factors and survival of  
young women with breast cancer: A population-based prospective cohort study. J Clin  
Oncol 2008 Oct 1; 26(28):4666-71. 
 
(16) Butow PN, Brown JE, Coates AS, Dunn SM. Psychosocial predictors of outcome 
IV: Patients with early-stage breast cancer. Breast 2001; 10(SUPPL. 3):182-9. 
 
(17) Osborne RH, Sali A, Aaronson NK, Elsworth GR, Mdzewski B, Sinclair AJ.  
Immune function and adjustment style: Do they predict survival in breast cancer?  
Psychooncology 2004 Mar; 13(3):199-210. 
 
(18) Lehto U-S, Ojanen M, Dyba T, Aromaa A, Kellokumpu-Lehtinen P. Baseline  
psychosocial predictors of survival in localised breast cancer. Brit J Cancer 2006 May 8;  
94(9):1245-52. 
 
(19) Greer S, Morris T, Pettingale KW: Psychological response to breast cancer: effect on  
outcome. Lancet 1979, 2:785-787.  
 
(20) Dean C, Surtees PG. Do psychological factors predict survival in breast cancer?  
J Psychosom Res 1989; 33(5):561-9. 
 
(21) Morris T, Pettingale K, Haybittle J: Psychological response to cancer diagnosis and  
 32 
disease outcome in patients with breast cancer and lymphoma. Psychooncology 1992,  
1:105-114.   
 
(22) Tross S, Herndon IJ, Korzun A, et al.  Psychological symptoms and disease-free and  
overall survival in women with stage II breast cancer. J Natl Cancer Inst 1996 May 15;  
88(10):661-7. 
 
(23) Kreitler S, Kreitler H, Chaitnic S, Shaked S. Psychological and medical predictors  
of disease course in breast cancer: a prospective study. Eur J Personality 1997, 11:383- 
400.  
 
(24) Gilbar O. The connection between the psychological condition of breast cancer  
patients and survival: A follow-up after eight years. Gen Hospital Psychiat 1996,  
18[4]:266-270.  
 
(25) Ramirez AJ, Richards MA, Gregory W, Craig TKJ.  Psychological correlates of  
hormone receptor status in breast cancer. Lancet 1990; 335:1408. 
 
 33 
Table 1 – Flow diagram of papers included and excluded at each search stage 
 
164 papers obtained from the computerised database searches 
 
 
55 were excluded on title alone, leaving 109 
 
 
A further 91 were excluded based on abstract, leaving 18 
 
 
On reading the full original papers 8 were excluded, because: 
 1 study included heterogeneous cancer sites, without separate analysis for participants with 
breast cancer (Exclusion criteria 1) 
 4 studies included participants with metastatic breast cancer (Exclusion criteria 2) 
 1 study assessed mortality in breast cancer and the psychological variable of cancer-related 
worry but both these variables were included as outcome variables (Exclusion criteria 4) 
 1 was a review article (Exclusion criteria 8) 
 1 article was reporting on the validity of a scale assessing dimensions of cancer locus of control 
in a French-speaking population.  It did report the association between this psychological 
variable and survival outcome for part of the sample but this information was reported in another 
paper in more detail, which was included in the final 10 articles (Exclusion criteria 9) 
 
 
A further 6 articles were included from reviewing reference 
lists of the 10 included articles and also review articles found 
in the literature search 
 
Each of the remaining 16 papers were rated for methodological 
quality using specific criteria 
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Table Two: Summary Table of Identified Studies including Methods, Sample Characteristics, Psychological Variables, Disease Outcome 
and Main Findings 
  
Study & 
Quality 
Rating 
Methods 
1. Sampling of Participants 
2. When Psychological 
Factors Assessed  
 
 
Sample 
1.  N 
2. Mean 
Age 
(years)  
3. Stage of 
Cancer 
 
Psychological Variables 
Examined 
 
Outcome  
1. Length of 
Follow 
2. 
Recurrence 
or survival 
outcome   
Main Findings 
 
Greer et al., 
1979 (19) 
 
(65%) 
1. Consecutive sample of 
convenience 
 
2. Preoperatively & 3 & 12 
months post-operatively and 
then annually for 4 years.  
 
- At follow up only ratings of 
depression & psychological 
response to cancer were 
repeated 
1. 69 (at 3 
months 
n=57)   
 
2.  not 
reported 
(< 70) 
 
3. T 0–1 
    N 0–1  
    M 0 
1. Depression (HRS) 
 
2.Hostility (HDHQ) 
 
3. Extraversion and 
Neuroticism  (EPI) 
 
4. Psychological response:  
- denial  
- fighting spirit  
- stoic acceptance 
- 
helplessness/hopelessness  
1. 5 years  
 
2.  
- 33 (49%) 
alive & no 
recurrence 
 - 16 (24%) 
alive with 
metastases  
- 18 (27%) 
had died of 
breast cancer  
- 2 died of 
other 
disorders 
 Recurrence-free 
survival was 
significantly more 
common among 
patients who reacted 
to cancer with denial 
or fighting spirit than 
among patients who 
responded with stoic 
acceptance and 
helplessness 
/hopelessness 
Dean & 
Surtees, 
1989 (20) 
 
1. Consecutive sample of 
convenience 
 
2. Before operation & three 
1. 121 
 
2. 48.7 
(20-60) 
1. Depression (RDC) 
 
2. Anxiety (RDC) 
 
1. Mean 6.7 
(0.77) years 
(range 6-8) 
 
 Participants assessed 
as an RDC case pre-
operatively were less 
likely to have a 
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(65%) months after operation.  
3. T0-2, 
N0-1, M0 
3. Coping response 
(assessed in interview and 
predominant coping 
response categorised by 
interviewer)  
 
4. Personality (EPI) 
2.  
- 37 
recurrences 
- 22 died (21 
of breast 
cancer) 
recurrence.  The 
association with 
survival did not reach 
significance 
 RDC assessed post 
operatively was not 
associated with 
recurrence or survival    
 Coping response 
employed post-
operatively was not 
significantly related to 
recurrence or survival, 
although survival for 
individuals employing 
a denial response was 
better than other 
responses. 
 Personality variables 
were not associated 
with cancer 
recurrence or survival 
outcome. 
 When demographic 
tumour and treatment 
variables were 
accounted for: 
- RDC cases (p<0.01), 
and individuals with a 
coping strategy 
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categorised as either 
hopeless/helpless or 
stoic (p<0.05) pre-
operatively were more 
likely to have been 
recurrence free 
- individuals 
employing a strategy 
categorised as denial 
(p<0.05) post-
operatively had a 
better chance of 
remaining recurrence 
free than all other 
coping strategies 
- these variables did 
not reach significance 
when performed in 
relation to survival 
Levy et al., 
1991 (9) 
(46%) 
1. Consecutive sample from a 
highly selective population 
 
2. Assessed approximately 5 
days after surgery & before 
they received any other 
adjuvant treatment 
1. 81 
 
2. 50 (28-
74) 
 
3. Stage 1 
or 2 
1. Measure of Mood State 
(POMS) 
- overall distress only 
assessed 
1. Minimum 
of 5 years 
(range: 5-8; 
60% 
followed up 
for 7 years or 
longer) 
 
2. 29 – 
disease 
recurrence 
 POMS score not 
predict if recurrence 
occur or not 
 Time to recurrence for 
those who relapsed 
(causal path 
modelling technique): 
- Lower POMS score 
at follow up 
associated with longer 
disease-free survival 
 37 
 
(excluded 
local 
recurrences, 
of which 
there were 9) 
- Indirectly a higher 
POMS score at 
baseline predicted a 
shorter time to 
recurrence via the 
path linked to the 
follow up POMS 
score.  
Barraclough 
et al., 1992 
(10) 
 
(85%) 
1. Consecutive sample of 
convenience 
 
2. Three interviews post-
operatively at 4, 24 & 42 
months 
 
 
1. 204 
 
2. 54.3 
(11.1)  
 
3. Breast 
cancer 
with no 
spread 
beyond the 
axilla 
1. Depressive 
symptomatology (DSM III 
criteria) 
 
1. 4 - 42 
months after 
operation 
 
2. Relapse of 
breast cancer 
in 47 (23%)  
- 26 of these 
died 
- 1 death 
unrelated to 
cancer 
 Prolonged major 
depression during 
follow up associated 
with a longer time to 
event (HR 0.85; CI 
0.41 to 1.79)  
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Morris et 
al., 1992 (21) 
 
(58%) 
 
1. Consecutive sample of 
convenience  
 
2. Interviewed at 3 months post 
diagnosis & further tests 
completed at 6 to 9 months 
post diagnosis and another 
interview at 12 months.  
1. 88 
 
2. No 
mean 
reported 
(Range: 
18-70) 
 
3. T 0–2, 
N 0–1, M 
0 
1. Anxiety (STAI) 
 
2. Depression (Wakefield 
Self Assessment 
Depression Inventory) 
 
3. Emotional Control 
(CECS) 
 
4. Patient's Responses to 
Diagnosis (PRD):  
- Fighting spirit (PRD 1) 
- Denial (PRD 2)  
- Anxious preoccupation 
(PRD 3)  
- Stoic acceptance (PRD 
4)  
- 
Helplessness/hopelessness 
(PRD 5) 
1. 5 year 
 
2.  
- 20 died  
- 8 alive with 
recurrence 
- 79 alive 
without 
recurrence 
 Psychological factors 
other than response to 
diagnosis were not 
associated with 
outcome 
 PRD code was 
associated with poorer 
survival (p = 0.06)  
 Association of PRD 
code with recurrence 
was not clear (p = 
0.15)  
 Patients with PRD 1 
and 2 had a better 
prognosis than 
patients with PRD 3–
5 although not 
statistically 
significant (p = 0.07 
for overall survival & 
p = 0.19 for 
recurrence) 
Tross et al., 
1996 (22) 
 
(62%) 
1. Consecutive sample from a 
highly selective population 
 
2. Assessment of psychological 
symptoms following surgery & 
prior to chemotherapy 
commencing 
 
1. 280  
 
2. Mean 
not 
reported- < 
40: 19% 
- 40-49: 
27% 
1. Symptom scores (SCL-
90-R) 
- Assesses: somatization, 
obsessive-compulsive 
symptoms, interpersonal 
sensitivity, depression, 
anxiety, hostility, phobic 
anxiety, paranoid ideation, 
1. 15 years 
 
2a. Disease 
free survival 
by GSI rating 
(years):  
- low: 7.48 
- med.: 7.04  
 No  evidence that 
psychological factors 
as measured by the 
GSI contributed to 
length of disease-free 
or overall survival 
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- 50-59: 
29% 
- 60-69: 
23% 
- ≥70: 3% 
 
3. Stage II 
psychoticism 
- Only Global Severity 
Index (GSI) used in 
analysis divided into 3 
subgroups: low, medium 
& high 
- high: 4.90  
 
2b. Overall 
survival by 
GSI rating 
(years): 
- low: 11.62 
- med.: 10.21 
- high: 9.58 
Gilbar, 1996 
(24) 
 
(42%) 
1. Selected at random from a 
convenience sample of 102 
patients who were receiving 
chemotherapy treatment  
 
2. Assessed approximately 2 
weeks post surgery 
1. 40 
 
2. 50.06 
 
3. Stage 1 
or 2 
1. Psychosocial 
adjustment to illness 
(PAIS) 
- 1 of 7 dimensions 
assesses psychological 
distress 
 
2. Psychological Distress 
(BSI) 
- 9 symptom areas & 
overall distress score 
(GSI) 
1. 8 years 
 
2.  
- 8 died 
- 7 developed 
bone 
metastases 
- 25 remained 
disease free 
 Participants who died 
had higher levels of 
psychological distress 
as measured by the 
PAIS & the following 
scales in the BSI: 
anxiety, hostility, 
paranoid ideation and 
GSI 
 Participants who 
developed metastasis 
had higher levels of 
anxiety 
 Length of survival 
was predicted by 
higher levels of 
anxiety and 
somatisation  
Buddeberg 
et al, 1996 
(13) 
1. Consecutive sample of 
convenience  
 
1. 107  
 
2. 52.6 
1. Coping strategies  
 
- ZQCI 
1. 5 to 6 
years after 
the primary 
 There is no steady 
significant 
relationship between 
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(73%) 
2. Assessed 6 months after 
surgery 
(29-70)  
 
3. T1-4, 
N0-1, M0 
Every 3 months in 1st year 
(assessments 1 - 5) & 
every 6 months during the 
2nd and 3rd year 
(assessments 6 - 9) 
 
- FQCI 
Every 12 months 
(assessments 1, 5, 7, 9). 
surgical 
treatment 
 
2 
- 66.4%  
recurrence-
free  
 - 1.9% local-
regional 
recurrence- 
5.6% distant 
metastases  
- 23.4% died 
from breast 
cancer  
- 1.9% 
developed a 
2nd 
carcinoma - 
0.9% died 
from cardiac 
disease 
the different coping 
strategies and disease 
outcome 
Kreitler et 
al., 1997 (23) 
 
(58%) 
1. Sampled from five hospitals 
participating in the study 
 
2. The mean time from 
assessment was 13.34 months 
after surgery or 9.89 months 
after the end of treatment. 
 
1. 96  
 
2. 53.13 
(10.04) 
 
3. Stage 
I&II 
1. Adjustment (PAIS) 
- one scale assess 
psychological distress 
 
2. Locus of control (Locus 
of Control Questionnaire) 
 
3. Anxiety (STAI) 
1. The health 
state of 
patients was 
examined at 
3 and 5 years 
after surgery  
- Follow-up 
was up to 
 Both medical and 
psychological 
variables are 
significant predictors 
for good health state 
on 3 years and 
survival on 5 years. 
 Higher levels of 
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five years 
 
2a. After 3 
years:  
- 73.96% 
good state of 
health  
- 1.04% died 
 
2b. After 5 
years:  
- 70.83% 
good state of 
health  
- 14.58% 
died 
psychological distress 
predict better health at 
3 years and overall 
survival 
 There was no 
significant association 
found for locus of 
control  
 Lower levels of 
anxiety were 
associated with better 
health at 3 years but 
not 5years.  Level of 
anxiety was not 
associated with 
survival. 
Watson et 
al., 1999 (11) 
 
(85%) 
1. Consecutive sample of 
convenience 
 
2. Psychological response 
measured 4 to 12 weeks and 12 
months after diagnosis 
 
 
1. 578  
 
2. 55 
(10.6) 
 
3. Stage I 
& II 
 
1. Patients' reactions to 
having cancer (MAC) 
-  fighting spirit  
-  helplessness or   
   hopelessness  
-  anxious preoccupation 
-  fatalism 
-  avoidance  
 
2. Extent suppress 
negative emotions (CECS) 
- anger  
- anxiety 
- sadness 
At 5 years,  
- 395 
(68.3%) 
women alive 
with no 
relapse  
- 50 (8.65%) 
alive with 
relapse 
-133 (23%) 
had died (122 
(21.1%) of 
breast 
cancer) 
 Assessment at 
baseline: - a high 
score on the 
depression scale 
associated with a 
significant increased 
risk of death from all 
causes by 5 years (HR 
3.59, 95% CI 1.39 to 
9.24).  
- High scores on the 
helplessness and 
hopelessness category 
significantly 
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3. Presence of depression 
or anxiety symptoms 
(HADS) 
 
associated with 
increased risk of 
relapse at 5 years, 
compared with 
women with a low 
score in this category 
(HR 1.55, 95% CI 
1.07 to 2.25).  
 Assessment at 1 year 
follow-up:  
- increased risk of 
death during follow 
up for the HAD scale 
category of 
depression remained 
significant (adjusted 
HR 4.04, 95% CI 1.54 
to 10.64) for a score 
>11 on depression 
scale.   
-   The association 
between a high 
helplessness or 
hopelessness score & 
event-free survival 
was reduced from 
baseline  and no 
longer significant 
 No associations found 
for other reactions, 
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anxiety or suppression 
of emotions  
Butow et al., 
2001 (16) 
 
(69%) 
1 Consecutive sample of 
convenience 
 
2. Assessment completed at a  
median of 90 days from 
diagnosis (mean 3.8 (2.3) 
months) 
1. 211 
 
2. 51 (11) 
 
3. Early 
stage 
breast 
cancer 
(Mean 
tumour 
size 1.3 
(1.6)) 
1. Cognitive appraisal of 
threat (13-item cognitive 
appraisal subscale of the 
Stress Questionnaire)  
- independence 
- family 
- disease 
 
2. Coping response 
(COPE) 
- active 
- distraction 
- avoidant 
 
3. Psychological 
adjustment ( PAC) 
1. Up to 2 
years 
 
2.  
- 30 (14%) 
died 
- 36 (17%) 
relapsed 
 Two psychological 
factors  independently 
predicted both longer 
overall survival and a 
longer time to relapse 
while controlling for 
tumour size, number 
of nodes involved and 
treatment:  
- Low levels of 
concern about disease 
- High levels of 
concern about 
dependence 
 Coping response & 
psychological 
adjustment were not 
significantly 
associated with either 
outcome 
Goodwin et 
al, 2004 (12)  
 
(77%) 
1. Consecutive sample during 
final 5 years of a larger 
prospective cohort study 
examining prognostic effects 
of a number of lifestyle-related 
factors 
 
2. Assessed 2 months after 
1. 397   
 
2. 52.0 
(9.9) 
 
3. T1 - T3, 
N0/N1 and 
M0  
1. Measure of Mood state 
(POMS) 
 
2. Stress response 
syndrome (IES) 
 
3. Coping Response  
(MAC) 
1. 50% of the 
patients were 
followed  ≥6 
years & 
0.75% (3) 
followed up 
for less than 
1 year 
 No consistency of 
associations across 
outcomes or 
questionnaires 
 No baseline measures 
were significantly 
associated with 
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diagnosis and 1 year later   
4. Emotional control 
(CECS) 
 
5. Psychosocial 
adjustment to illness 
(PAIS-SR)  
-includes a scale assessing 
psychologic distress 
 
2.  
- 55 
(13.85%) 
distant 
recurrences 
- 34 (8.56%) 
died of breast 
cancer  
- 2 (0.5%) 
experienced 
non-breast 
cancer-
related deaths 
outcome 
 At 1 year the 
avoidance subscale on 
the IES was 
associated with OS (p 
= 0.014), suggesting 
higher scores on this 
subscale was 
significantly 
associated with a 
lower risk of death  
 Out of 140 
investigated 
prognostic 
associations, only 4 
were statistically 
significant which was 
less than expected by 
chance 
Osborne et 
al., 2004 (17)  
 
(73%) 
1. Consecutive sample of 
convenience 
 
2. Approximately two-thirds of 
the sample were interviewed 
between 5 and 9 months 
following diagnosis, the 
remaining one-third was 
interviewed 9 to 17 months 
following diagnosis 
 
1. F - 61  
 
2. 56 (27-
75) 
 
3. T1-3, 
N0-1, M0 
1. Anxiety (HADS)  
 
2. Depression (HADS)  
 
3. Mental adjustment to 
cancer (MAC - Australian 
form) 
- Fighting spirit - 
minimising the illness 
- Fighting spirit – positive 
orientation to the illness 
1. Follow up 
time ranged 
from 6.1 to 
7.9 years 
 
2a. Overall 
survival:   
- 18 (29%) 
died  
- 14 (23%) 
from breast 
 No statistically 
significant effects of 
anxiety or depression 
on survival were 
found  
 High score on 
subscale assessing 
fighting spirit - 
minimizing the illness 
was associated with 
longer survival (HR 
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 - 
Helplessness/hopelessness 
- Fatalism 
- Loss of control 
- Angst (strong negative 
affect) 
cancer  
- 3 from 
other causes 
&1 case the 
cause of 
death could 
not be 
verified  
 
2b. 5 years 
after 
diagnosis 
there were 11 
deaths (18%) 
0.77, p = 0.008).  
 No substantial 
evidence for a link 
between psychosocial 
factors and biological 
factors. 
Lehto et al., 
2006 (18) 
 
(73%) 
1. Consecutive sample of 
convenience  
 
2. Interviewed 3 to 4 months 
after diagnosis 
 
1. 101   
 
2. 54.2 
(8.45)  
 
3. Stage 1-
3 
1. Coping Response 
(WOC-CA) 
- Focusing on positive 
- Distancing 
- Seeking & using social 
support 
- Cognitive escape-
avoidance 
-Behavioural escape 
avoidance  
 
2.Anger Expression  
(AX/Scale)  
 
3. Emotional Expression 
(R/ED) 
1. From 8 to 
9 years (Jan 
1996-15
th
 
February 
2005)  
- Event-free 
survival 
- Overall 
survival  
2. By 15 
February:  
- 31(30.7%) 
relapsed  
- 20 (19.8%) 
died 
 In univariate analysis: 
- Emotional 
defensiveness (p = 
0.007) and 
behavioural escape-
avoidance (p = 0.057) 
were significantly 
associated with 
shorter survival.  
 In multivariate 
analysis:  
- Distancing 
(minimising) coping 
was associated with 
longer overall 
survival (p = 0.034).  
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4. Depression Scale 
(DEPS) 
 
 
 
- Emotional 
defensiveness (anti-
emotionality; p = 
0.021), behavioural 
escape-avoidance 
coping (p = 0.008), 
and high level of 
perceived support (p 
= 0.009) were 
associated with 
shorter overall 
survival.  
- Depressive 
symptoms had a 
survival-decreasing 
effect before the 
coping patterns were 
added into the final 
models (p < 0.05).  
- Depressive 
symptoms tended to 
predict a shorter 
event-free time 
survival ( p = 0.066) 
Cousson-
Gelie et al., 
2007 (14) 
 
(73%) 
1 Consecutive sample of 
convenience 
 
2. 3 weeks after diagnosis & 
treatment plan confirmed 
1. 75 
 
2. 48 (9.8) 
 
3. Stage II-
III (T2-4) 
1. Coping (WCC-R)  
- Problem-focused coping  
- Emotion-focused coping  
- Seeking social support 
 
2. Anxiety (STAI) 
1. 10 years 
 
2. 43 (57.3%) 
died 
- 37 of breast 
cancer 
 No significant 
association between 
the type of coping 
strategy employed 
and outcome 
 After adjustment low 
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 - 6 cause not 
specified 
 
- survival 
analysis 
based on 69 
- 32 (46.4%) 
alive 
- 37 (53.6%) 
dead 
anxiety scores were 
significantly 
associated with an 
increased risk of death 
Phillips et 
al., 2008 (15) 
 
(69%) 
1. Highly selective sample – 
recruited incident cases of 
breast cancer with younger age 
groups being oversampled. 
 
2. the median time between 
diagnosis and interview was 11 
months (range: 2-42 months) 
1. 708 for 
overall 
survival & 
638 for 
distant 
disease 
free 
survival 
 
2. 40 (8.2) 
 
3. Non-
metastatic 
breast 
cancer 
(size <20-
>50 mm) 
1. Anxiety (HADS) 
 
2. Depression (HADS) 
 
3. Adjustment or response 
to cancer (MAC) 
 -  fighting spirit  
-  helplessness/ 
hopelessness  
-  anxious preoccupation 
-  fatalism 
-  avoidance  
 
4. Emotional control 
(CECS) 
1. Median 
follow up 8.2 
(range: 0.8-
14.4) years 
 
2.  
- Overall 
Survival: 170 
(24%) died   
- Distant 
Recurrence: 
209 (33%) 
 Adjusted analysis: no 
significant association 
between any 
psychological factors 
and either outcome 
 Unadjusted analysis: 
Higher scores on 
anxious preoccupation 
scale associated with 
poorer outcomes 
when analysed as a 
continuous variable 
(p=0.02) 
 Allowing this 
association to depend 
on the time delay 
between diagnosis & 
assessment showed 
there was no 
association of delay 
 48 
 
with death (p=0.7); 
but there was a 
tendency for the  
association with 
recurrence to be 
weaker if the data 
were collected further 
from diagnosis 
(p=0.08) 
*See Appendix 1.3 for full titles of psychological measures. 
 49 
 
CHAPTER TWO: MAJOR RESEARCH PROJECT 
 
An Investigation of Personality Factors and Beliefs about Illness that 
may Influence the Time Taken to Seek Help for Cancer Symptoms 
 
Short Title: Factors that Influence the Time Taken to Seek Help for Cancer Symptoms 
 
 
Lynn Steele¹
*
& Professor Keith Millar¹ 
 
 
Prepared in accordance with submission guidelines for Psycho-Oncology  
(See Appendix 2.1) 
 
 
Submitted in partial fulfilment for the requirements of the degree of Doctorate in 
Clinical Psychology 
 
1
Section of Psychological Medicine, University of Glasgow 
 
*Address for Correspondence:   
Division of Community Based Sciences 
University of Glasgow 
Gartnavel Royal Hospital 
1055 Great Western Road 
Glasgow 
G12 0XH 
 
Tel: +44 (0141) 211 0607 
Fax: +44 (0141) 211 0356 
E-mail: lynnsteele@nhs.net 
 50 
 
Abstract 
Background: Reducing the time taken to seek help for symptoms is important in 
improving prognosis for cancer patients.  Delay in help-seeking refers to the period 
between first noticing symptoms and initial medical consultation.  The aim of this study 
was to investigate if psychological factors were associated with the time taken to seek 
help for individuals with colorectal or breast cancer.  
Method: Participants with colorectal (47) and breast cancer (24) recalled the length of 
time from first recognising symptoms until seeking medical help.  This was calculated 
in days for two sequential time periods: symptom appraisal (from recognising 
symptoms until appraising they may be serious) and action appraisal (from recognition 
of symptoms as serious until organising a medical consultation).  Six measures 
assessing dispositional traits, illness beliefs and current symptomatology were 
completed, and relevant demographic information recorded. 
Result: Symptom appraisal accounted for the largest proportion of time in seeking help 
for both groups.  Initial correlational analysis followed by further Cox regression 
analysis indicated that age was significantly associated with action appraisal time for the 
breast cancer group.  There were no significant associations between predictor variables 
and symptom appraisal time for this group.  Time-to-event analysis could not be 
completed for participants with colorectal cancer.  
Conclusion: Results are discussed in light of previous research findings and the 
limitations of the present study. 
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Introduction 
Reducing the time taken to seek help has been highlighted by the Scottish Government 
and Cancer Research UK as part of broader initiatives to reduce mortality from 
cancer[1;2].  Data gathered by the Scottish Primary Care Cancer Group, show patients 
frequently have symptoms for a considerable period of time before seeking help, with 
delays ranging from 30 to 80 days depending on cancer site[1].  Therefore, an 
understanding of the factors that determine the timing of treatment remains paramount.  
This study will focus on colorectal and breast cancer as they often have more 
identifiable symptoms to a lay person, such as rectal bleeding or a lump[3].  The 
presence of identifiable symptoms however, does not ensure that individuals will seek 
help for symptoms.  For example, a questionnaire survey regarding rectal bleeding of 
any cause in general practices indicated that over half the respondents did not seek 
consultation[4].  Breast cancer is the most frequently diagnosed cancer in Scottish 
women, accounting for twenty eight percent of all cancers diagnosed in females[1].  
Incidences of colorectal cancer in Scotland rank among the world’s highest[5].  Studies 
indicate that survival rates for colorectal cancer in the UK are poorer than in Europe[6], 
due mainly to late diagnosis, resulting in high emergency rates being linked to higher 
death rates in the first six months[6;7].  Untreated cancer advances in stages, and early 
stage treatment improves long term survival prospects[8].  A systematic review found 
delays greater than twelve weeks from onset of symptoms until treatment commencing 
in breast cancer patients were associated with poorer survival rates and a more advanced 
stage[9].   
 
Reasons for Delay in Help-seeking 
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Understanding the factors influencing time taken to seek help is a prerequisite for the 
development of strategies to shorten delay.  There is evidence that both demographic 
and psychological factors are associated with delays in seeking medical help[10;11].  
Some studies indicated high levels of anxiety and beliefs about prognosis are 
paramount, while others found low levels of initial emotional distress were associated 
with treatment delay[12].  A systematic review examining the role of fear in help-
seeking concluded that high levels of fear were associated with earlier help-seeking 
while the evidence for low levels of fear was unclear[13].  The processes involved in 
help-seeking are probably multifaceted and individual differences such as dispositional 
traits may mediate these processes. 
 
[Insert Figure 1] 
 
Delay Stages and Psychophysiological Comparison Processes 
Andersen and colleagues presented a model of ‘total delay’, which describes the time 
between an individual first noticing symptoms until receiving treatment[14].  The five 
dichotomous stages (appraisal, illness, behavioural, scheduling and treatment delay), 
can facilitate the investigation of factors contributing to delay at each stage (Figure 1).  
The first three stages are influenced by patient delay only, while scheduling and 
treatment delay can be influenced by patient delay and professional delay.  Research 
indicates that the majority of delay is accounted for by patient delay with appraisal 
delay being the longest portion[14-16].  Therefore, the psychological processes 
involved during this period are of particular interest.   
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Andersen et al[17] developed an attributional framework, called the 
Psychophysiological Comparison Theory outlining the psychological processes 
governing symptom appraisal (see Figure 2).  It highlights that an individual’s 
perception of a set of symptoms is influenced by their knowledge of physiological 
conditions.  There is evidence from a study of a general female population that although 
more marked for older participants, all age groups had limited knowledge about their 
relative risk of developing breast cancer and the diversity of potential breast cancer 
related symptoms[18].  The framework also suggests that symptom appraisal is biased 
to support a positive view of the individual’s physiological condition.  This suggests a 
role for both personality factors and illness representations contributing to symptom 
appraisal.  Illness representations are implicit theories individuals hold about an illness 
and can influence how they respond to a perceived health threat[19].  The model 
includes both cognitive and emotional representations of an illness which can be highly 
idiosyncratic[19].  There are five main cognitive components: the identity of the illness; 
personal beliefs about aetiology; the timeline of the illness; perceived consequences of 
the illness and the degree of control an individual has.  The cognitive component of the 
model has been shown to account for approximately 22% of the variance in help-
seeking intention for breast cancer in a female population[20]. 
 
[Insert Figure 2] 
 
Individual Differences & Delay in Help-seeking 
There has been limited research into the role of personality traits and health behaviours 
in relation to cancer and help-seeking.  One study investigated the association between 
patient delay in rectal cancer and a dispositional trait defined as ‘Trait Anxiety’[16].  In 
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the literature this trait has been referred to as ‘Neuroticism’[21], ‘Negative 
Affectivity’[22] and ‘Trait Anxiety’[23].  These terms reflect different perspectives but 
there is consensus that it is the degree of tendency towards anxiety, worry and negative 
emotions in general [16] (page340).  In this study we will adopt the term Trait Anxiety.  
Ristvedt & Trinkaus identified two stages of patient delay using Andersen’s model: 
‘appraisal delay’ and ‘action delay’[16], of which the latter combines Andersen’s illness 
and behavioural delay[14].  They examined whether low Trait Anxiety was associated 
with longer symptom appraisal times and if there was any association with action 
appraisal times.  Trait Anxiety was measured using the Temperament and Character 
Inventory Harm Avoidance Scale (TCI-HA)24] and the Spielberger State Trait Anxiety 
Inventory – Trait Anxiety Scale (STAI-T)[25]. 
 
They found no associations for either measure with action appraisal time.  Longer 
symptom appraisal time was associated with low scores on the TCI-HA,
 
while 
significance was not met using the STAI-T.  The psychological measures were 
trichotomized, with individuals defined as scoring low, medium and high on the 
variable of interest to compare ‘group’ differences.  Methodologically this is not 
recommended as it results in the loss of information, loss of measurement reliability and 
reduction in power causing the reliability of this result to be questioned[26-28].  
Overall, the study concluded that individuals with a dispositional insensitivity to threat 
had longer appraisal times.  It was postulated that the reason for the difference between 
the measures was that the STAI-T includes cognitive and somatic aspects of anxiety, 
while the TCI-HA only focuses on cognitive aspects of anxiety.   However, it is also 
plausible that the construct of optimism was influencing the discrepancy between these 
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two measures, as individuals scoring lowly on the TCI-HA are characterised as 
optimistic.   
 
Individual Differences & Health Related Behaviour 
Highly optimistic individuals tend to hold more positive expectations for their future 
than pessimists[29].  There is evidence that positive life orientation is beneficial to 
health; having been associated with better recovery and quality of life after coronary 
artery bypass surgery[30], and with lower levels of distress pre and post surgery among 
patients with early stage breast cancer[31].  Optimists tend to use more problem-focused 
coping strategies than do pessimists[29;31].  Optimism has also been associated with 
increased frequency of breast self-examination[32].  Therefore, when considering action 
appraisal time it is likely that optimistic individuals will seek help sooner.  Andersen 
and colleagues propose that symptom appraisal is governed by an optimistic bias 
(Principle 6)[17], whereby an innocuous transient cause for symptoms is more likely to 
be generated.  Therefore, more optimistic individuals may be expected to have longer 
symptom appraisal times. 
 
Another personality construct not previously addressed is conscientiousness, which is a 
dispositional ‘tendency to be prudent, planful, persistent (and) dependable’ (page 
1099)[33].  There appear to be links between conscientiousness and longevity, with 
healthier behaviours and adherence to medical advice being likely mechanisms[33;34].  
It is possible, therefore, that conscientious individuals may have shorter action appraisal 
times.  Another potentially relevant personality trait is openness to experience.  Less 
open individuals are less aware of the effects of ill health (Costa & McCrae, 1984 cited 
in[35]).  Therefore, individuals who are more open when appraising symptoms may be 
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better able to notice new symptoms and offer new interpretations, including that the 
symptom may be serious.  
 
Although the psychological characteristics being investigated in this study are not easily 
amenable to change, they could provide direction for identifying groups at greatest risk 
for misinterpreting cancer symptomatology and delaying.  The Scottish Primary Care 
Cancer Group advised that public education programmes on common cancer symptoms 
be developed and disseminated to encourage patients to present early[36].  Identifying 
characteristics of at risk populations would have implications for the development of 
educational material, future public health initiatives and would inform practice, which 
may reduce delay time and increase survival rates.   
 
Aims and hypotheses 
The primary aim is to examine the association between dispositional traits and the time 
taken to appraise symptoms and seek professional advice.  A secondary aim is to 
examine the association between illness representations and the time taken to seek help.   
 
1. A low level of trait anxiety will be associated with longer symptom appraisal time. 
2. High optimism will be associated with longer symptom appraisal times and shorter 
action appraisal times.     
3. Conscientiousness will be associated with shorter action appraisal times. 
4. Openness to experience will be associated with shorter symptom appraisal times.  
 
Methods 
Participants 
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Continuous samples of participants receiving treatment for a primary diagnosis of breast 
cancer or colorectal cancer were recruited from a cancer centre.  All participants spoke 
English and were aged 18 years or over.  Participants whose symptoms were detected 
by a medical health care provider or screening programme independent of self-
discovery were excluded as they had no opportunity to appraise their symptoms 
independently.  Individuals with a cognitive impairment or learning disability were also 
excluded.   
 
Procedure 
One hundred and fifty-two individuals met criteria and seventy-four agreed to take part.  
Reasons for declining to take part included being unwell, additional stressful life events, 
participation in another study, transport problems and being hearing impaired.  
Participants completed six measures, followed by a brief semi-structured clinical 
interview where participants provided an estimate of the time taken to appraise 
symptoms and seek help in days.  A calendar, prompt questions and cues as anchoring 
events were employed to facilitate recall (Appendix 2.7). 
 
Demographic information was also collected (cancer site, age, gender and socio-
economic status). Socio-economic status was defined using the Scottish Index of 
Multiple Deprivation (SIMD) by quintile categories (1 = most deprived; 5 = least 
deprived)[37]. 
 
Measures 
Temperament and Character Inventory – Harm Avoidance Scale (TCI-HA)[24] 
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TCI-HA is a short self-report form measuring individual differences in sensitivity to 
signals of possible threat, danger or punishment.   
 
Spielberger State Trait Anxiety Inventory – Trait Anxiety Scale (STAI-T)[25] 
STAI-T contains twenty statements assessing the degree of predisposition to respond in 
an anxious manner to trigger situations.  It shows good reliability with coefficients of 
between 0.75-0.88[38]. 
 
 
NEO Five-Factor Inventory (NEO5)[39] 
NEO5 is a 60-item shortened version of the Revised NEO Personality Inventory[40].  It 
was used to measure Neuroticism (N), Openness to Experience (O) and 
Conscientiousness (C).  Internal consistency for each of the scales indicates coefficients 
of 0.86, 0.73 and 0.81 respectively[40]. 
 
Revised Life Orientation Test (LOT–R)[29] 
LOT-R is a 10-item self-report measure assessing individual differences in generalized 
optimism with higher values indicating higher levels of optimism. 
 
The Brief Illness Perception Questionnaire (BIPQ)[41] 
BIPQ is a 9-item self-report measure assessing the cognitive and emotional 
representations of illness proposed in Leventhal's self-regulatory model[19]. 
 
Hospital Anxiety and Depression Scale (HADS)[42] 
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HADS is a 14-item scale designed to detect the presence of depressive and anxiety 
symptomatology.  Internal consistency has previously been reported to be between 0.80 
and 0.90 for both anxiety and depression subscales[43].  This was included to assess 
any possible confounding variables that may impact on recall. 
 
Sample size and power 
Sample size was determined on the basis of a cross-sectional design and according to 
the procedures required when regression analysis is to be applied to the data[44].  
Unfortunately, there were no relevant effects sizes reported in the literature to estimate 
the effect size for the present study so the convention of a medium effect size of 0.15 
was applied.  Power was set at 0.80 and alpha at 0.05.  As predictor variables with co-
linearity, for example NEO5-N, TCI-HA and STAI-T cannot be entered simultaneously 
to a regression analysis; the number of predictive variables was set at seven.  
Considering this it was estimated that the required sample size to test the hypotheses 
would be 103 participants[45]. 
 
Statistical Analysis 
All analyses were performed using the Statistical Package for Social Sciences[46].  
After reviewing the data, cancer sites were investigated independently as there were 
apparent differences in the time taken to seek help.  Preliminary analysis of the 
variables for the colorectal cancer participants indicated a non-normal distribution 
(Kolmogorov-Smirnov test of normality p<0.05) for time, STAI-T, TCI-HA, BIPQ and 
HADS.  In the breast cancer sample time, STAI-T and items 4 and 7 of the BIPQ had a 
non-normal distribution.  Also a number of variables were skewed across both groups 
so Spearman’s rank order correlations were conducted to examine associations between 
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variables.  As the assumptions of multivariate analyses were not met the intended 
regression analyses were not conducted. 
 
Cox regression analysis was able to be completed.  The event of interest in symptom 
appraisal is the point when an individual becomes aware of the seriousness of their 
symptoms.  For some participants the event of interest, however, did not occur before 
seeking a medical consultation.  Cox regression analysis allows the inclusion of data 
points for participants who did not appraise their symptoms as serious prior to medical 
consultation, as censored observations.  Cox regression analysis was repeated to predict 
action appraisal time.  The event of interest here was arranging an appointment.  
Measures assessing dispositional traits were not trichotomized. 
 
Results 
Participant Characteristics & Time Taken to Seek Help 
Three of the seventy-four participants were excluded from the analysis as they could not 
accurately estimate the time taken to seek help.  Table 1 summarises the characteristics 
of the participants by cancer site.  Table 2 summarises the time taken to seek help.  
Fifteen participants with colorectal cancer waited for three or more months; and three 
waited longer than a year.  On average symptom appraisal accounted for 87.83% of the 
total time taken to seek help.  There was a positive medium association between the two 
appraisal times (Spearman’s rho = 0.301; p=0.04).  Four participants with breast cancer 
waited for three or more months with none longer than a year.  On average symptom 
appraisal accounted for 89.23% of the total time taken to seek help.  There was a 
positive medium association between the two appraisal times (Spearman’s rho = 0.398; 
p=0.05).   
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Summary Data for Relevant Psychological Data 
Table 3a and 3b present outcome data for the measures assessing dispositional traits and 
current anxiety and depressive symptomatology.  Across both groups the data were 
positively skewed on all measures of trait anxiety, NEO5-O and HADS.  Within the 
colorectal group the LOT-R and NEO5-C were negatively skewed and in the breast 
group only the LOT-R was negatively skewed.  Therefore the frequency of scores 
across clinical cut off points was explored for the STAI-T, NEO5 and HADS based on 
published data and are summarised in Table 4.  The TCI-HA, LOT-R or BIPQ do not 
have clinical cut-off points.  The majority of the sample in the colorectal group (96%) 
and all the breast cancer participants scored in the normal to mild range on the STAI=T.  
The majority of the colorectal group (89%) and breast cancer group (88%) scored in the 
low to average range on the NEO5-N.  Likewise only a very small number of the 
sample reported a high degree of openness to experience in the colorectal group (4%) 
while this was only slightly higher in the breast cancer group (25%).  Very few of either 
sample rated low on conscientiousness (colorectal group: 11%; breast cancer group: 
17%). 
 
The HADS was administered to assess if current symptomatology impacted on recall of 
the time taken to seek help.  As can be seen in Table 4 the majority of both samples 
scored in the ‘normal’ range and only a small number reported significant levels of 
depressive or anxious symptomatology.  These individuals did not have difficulty 
recalling the time taken to seek help, so HADS scores were not included in the 
correlational analysis. 
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Breast Cancer 
Table 5a summarises correlations which approached or reached significance between 
the predictor variables and the time taken to appraise symptoms as serious.  Only the 
predictors which were significantly correlated or close to significance were included in 
the time-to-event analysis.  Two individuals were censored so analysis was based on 
twenty-two participants and the global null hypothesis was not rejected (chi-square = 
7.509; p = 0.28; df = 6). 
 
Table 5b summarises the correlations which were significantly associated with action 
appraisal time, which were then included in the time-to-event analysis and was based on 
twenty-two participants.  The global null hypothesis was rejected (chi-square = 9.363; p 
= 0.03; df = 3).  As seen in Table 6 older participants took less time acting on their 
symptoms, but no other variables were predictive.  
 
Colorectal Cancer 
There were no significant correlations between the predictor variables and the length of 
time taken to appraise symptoms.  The only variable which approached significance was 
personal control (item three of BIPQ) (Spearman’s rho = -0.257, p = 0.082).  For action 
appraisal time there was a significant association with the level of deprivation only 
(Spearman’s rho = 0.327, p = 0.025).  Therefore Cox regression analyses were unable to 
be performed for this group. 
 
Discussion 
This study investigated the association between the time taken to seek help and 
dispositional traits and illness beliefs, specifically considering the time taken to appraise 
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symptoms and the time taken to act thereon.  The study aimed to examine if findings by 
Ristvedt & Trinkaus could be replicated in this population[16].  Also other dispositional 
traits and illness beliefs were included to explore further the possible influence of 
psychological variables on symptom and action appraisal time. 
 
Time Taken to Seek Help 
The results indicated that across both groups there was evidence of delay in help-
seeking and the time taken to appraise symptoms on average accounted for the majority 
of the total time taken to seek help.  This supports other findings in the literature [14-
16;47;48].  The results indicated that on average participants with colorectal cancer took 
longer to appraise symptoms and seek help than breast cancer patients (median total 
time 49 days Vs 12.5 days).  The ranges reported in these two samples were longer than 
the time estimated from the data gathered by the Scottish Primary Care Cancer 
Group[1].  It is important to note, however, that delay times were skewed and 71% of 
the breast cancer participants sought help within a month and 83% within three months.  
For the colorectal group 40% sought help for their symptoms within a month and 70% 
within three months.  The time taken to seek help in this study for breast cancer patients 
was within similar ranges reported for other studies[8].  The length of time taken to seek 
help for participants with colorectal cancer was shorter than some of the lengths 
reported in the literature.  A systematic review indicated that median patient delay for 
patients with colorectal cancer ranged from seven days to five months[49].  The shorter 
time to presentation in this sample may reflect the NHS setting of this study.  This may 
be a factor to consider in comparison to studies completed in settings without a national 
health service.  Overall, these results highlight that an understanding of the factors that 
determine the timing of treatment remains of paramount importance.  
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Dispositional Traits 
Hypothesis one proposed that participants with low levels of trait anxiety would have 
longer symptom appraisal times.  Contrary to the previous study by Ristvedt & Trinkaus 
no significant correlations were found between the TCI-HA and symptom appraisal 
time[16].  In this study trait anxiety was measured by three scales: TCI-HA, STAI-T 
and NEO5-N.  The latter two measures did not meet significance either although the 
relationship between symptom appraisal and NEO5-N for the breast cancer group was 
approaching significance.  This was a positive relationship indicating a higher degree of 
neuroticism resulted in longer symptom appraisal but when this variable was included 
in the Cox regression model it was not predictive.  Data analysis for the scales 
measuring trait anxiety indicated that they were positively skewed across both groups.  
The mean and median scores for the STAI-T were within normal limits.  The mean and 
median scores were within the low range for the NEO5N scale.  An unequal distribution 
across the range of scores means it was unlikely that an association with symptom or 
action appraisal time would have be found.  Although there are not clinical cut-offs 
provided for the TCI-HA the mean and median scores for both groups were well below 
the median point on the scale.  The original study did not report the mean score or range 
for the TCI-HA or the STAI-T so a proper comparison could not be made. 
 
Hypothesis two predicted that a high degree of optimism may be associated with longer 
symptom appraisal times and shorter action appraisal times.
  
Although scores for the 
LOT-R were skewed towards higher levels of optimism there was a significant 
correlation between the LOT-R and symptom appraisal time in the direction predicted 
for the breast cancer group.  The Cox regression analysis however did not indicate that 
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symptom appraisal time was significantly associated with the six variables identified as 
predictive.  There was no association between the LOT-R and action appraisal for this 
group and no associations for either appraisal time in the colorectal group.  The 
correlation between the LOT-R and symptom appraisal time provides some preliminary 
support for the association between optimism and the symptom appraisal process and 
therefore warrants further investigation with a larger sample size.  This may also result 
in a more equal distribution in the levels of trait optimism. 
 
Hypothesis three predicted a high degree of conscientiousness would be associated with 
shorter action appraisal times.  There was no association found between these variables 
for either group.  The scores for conscientiousness were negatively skewed for the 
colorectal group and centred in the middle range for the breast cancer group, which may 
limit the possibility for an association being found.  This may be an artefact of 
recruitment with more conscientiousness individuals being implicitly more likely to 
participate in a study. 
 
Hypothesis four predicted that more openness to experience would be associated with 
shorter symptom appraisal times. There was no association for this trait with symptom 
appraisal time for either cancer site.  It was postulated that individuals with higher 
levels of openness to experience, may be better able to notice new events and provide 
new interpretations.  In the colorectal group investigation of the score ranges illustrate 
that the mean and median scores for the openness to experience were in the low to 
medium range with only two individuals in the high range, which may elude the finding 
of a significant association.  In the breast group, however, scores were more equally 
distributed across the ranges and there was still no evidence of a significant association.   
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Using a Cox regression model older age was found to be associated with shorter action 
appraisal times in the breast cancer group.  This finding is contrary with the results of a 
systematic review of the literature for breast cancer and help-seeking, which indicated 
that older age was associated with increased patient delay[47].  That review however, 
did not consider the stages within patient delay but conceptualised it as one time period.  
One possible explanation for this finding is that the older participants were often retired 
and may have more time and fewer factors, such as a young family or work as barriers 
to seeking help after appraising symptoms as serious.  This highlights the importance of 
considering the processes within patient-delay separately to facilitate the investigation 
of factors that contribute to overall delay, which might otherwise be overlooked.  There 
was no evidence of age being associated with appraisal times in the colorectal cancer 
group.  This is in line with the overall findings in the literature, which indicate that age 
has no impact on total patient delay for individuals with colorectal cancer[47].   
 
Illness Representations 
The second aim of this study was to examine the association between illness 
representations and the time taken to seek help.  Illness representations were explored as 
the Psychophysiological Comparison theory highlights that the implicit theories 
individuals have about an illness will influence their attention to symptoms and the 
appraisal process[17].  The Cox regression models did not find a significant association 
between illness representations and time taken to appraise or act upon symptoms for 
either group.  Spearman’s correlations, however, indicated that in the breast cancer 
group longer symptom appraisal times were associated with more perceived severe 
consequences, more symptoms being viewed as being part of the illness, more concern 
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and a stronger emotional impact.  Longer action appraisal times were associated with 
more perceived severe consequences with regard to the diagnosis and a stronger 
emotional impact. 
 
Participants had been asked to complete the BIPQ with regard to their perception of 
their illness at diagnosis.  It is likely that many individuals who took longer to seek help 
were at increased risk of being diagnosed with a later stage of cancer and so have a 
poorer prognosis.  Therefore these individuals may indeed have experienced more 
symptoms and actual severe consequences and as a result concern when diagnosed.  
Unfortunately as this is a retrospective study it is difficult to assess illness beliefs about 
symptoms prior to confirmation of diagnosis using the BIPQ.  Anecdotal evidence 
gathered during data collection indicated that participants who took longer to appraise 
their symptoms as serious did initially attribute symptoms to benign causes or did not 
know their symptoms were associated with a particular cancer type.  Another study 
using a regression model found that not having a breast lump and lower initial symptom 
distress were the most important factors in delaying to seek help[12].  Also a summary 
of two systematic reviews indicate that across symptomatic cancer sites, non-
recognition of symptom seriousness is the main patient-mediated factor resulting in 
increased time to presentation[47].  Therefore it may have been useful to record 
information about the type of symptoms and the participant’s initial perceptions of them 
as well as their knowledge of cancer-related symptoms before being diagnosed as it 
seems likely that this would mediate shorter times to presentation. 
 
Limitations of Study 
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There are a number of limitations to the present study that must be considered.  The use 
of a cross-sectional design limits the conclusions that can be drawn about causality.  As 
it is retrospective it is subject to recall bias and error.  It would however be difficult to 
measure length of time without medical intervention in any other way as we wanted to 
identify predictive factors for individuals who took longer to seek help.  Retrospective 
studies such as this can contribute to initial investigations where there are a number of 
possible interacting factors to identify which are important to explore further in a 
prospective study.   
 
Another limitation is that the estimate of the time taken to seek help was provided by 
patient self-report.  Firstly, there is the possibility of a recall bias as participants account 
for their past actions with respect to their current diagnosis.  The length of delay 
reported, however, by many participants was significant and so does not support the 
hypothesis that individuals underreported the time taken to seek help.  Anecdotal 
evidence indicated that individuals did not underestimate the time taken to seek help but 
generated explanations for why they took time to seek help.  Secondly, the literature 
indicates that there is significant variability in the recall of illness related information 
over time[50;51].  Steps were taken to minimise recall error by completing data 
collection during treatment so to be as close to the actual occurrence of symptoms, 
while allowing for initial adjustment to the diagnosis.  Despite this the time since first 
recognising symptoms for some participants was up to two years.  It could be argued 
that self report measures assessing individual differences could also be subject to bias.  
The time constraints of this study did not allow for a prospective study to be carried out, 
whereby participants completed psychological measures prior to the possible 
development of any cancer symptoms and were followed up for a significant number of 
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years.  Therefore within the time restrictions of this study the measures assessing 
dispositional traits have been shown to be relatively stable over time.  For example, 
individual differences based on the TCI-HA are observable in early childhood and are 
moderately predictive of adult behaviour[52]. 
 
The major limitation of this study is that it did not have an adequate sample size; the 
number of participants was significantly less than the number generated by the a priori 
power calculation resulting in a reduction in the statistical power of the study.  Further 
to this the data for the sample were analysed separately by cancer type reducing the 
statistical power further.  There was evidence that there were significant associations or 
trends approaching significance between the appraisal times and some of the predictor 
variables.  This initial study would indicate that it would be worthwhile to complete this 
study over a longer period of time to increase the sample size.  Related to this is the 
finding that the frequencies of scores on the measures assessing dispositional traits were 
significantly skewed and did not result in large enough numbers at both the lower and 
upper scales of measures.  This may be addressed in some part by a larger sample size 
but may also be an effect of recruitment; with more optimistic, conscientious and less 
depressed and neurotic or anxious individuals agreeing to participate.  The degree of 
depressive and anxiety symptomatology reported in this study however does not differ 
significantly from other studies in the literature[53]. 
 
Conclusions 
This study aimed to assess whether dispositional traits and illness representations were 
associated with the length of time taken to seek help.  None of the hypotheses were 
confirmed but as highlighted there were a number of limitations as a result of time 
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constraints in this particular study.  Despite these limitations there does seem to be 
evidence to suggest that examination of dispositional traits and illness beliefs is 
worthwhile to enable identification of individuals who are at risk of taking longer to 
seek help.  Specifically this study indicated that with breast cancer patients, it may be 
worthwhile to further explore the association between neuroticism and symptom 
appraisal and optimism and both symptom and action appraisal.  All further research 
investigating dispositional traits and illness beliefs would be strengthened by 
investigating and analysing data for different cancer types separately.  Anecdotal 
evidence indicated that the study would have benefitted from recording the specific type 
of symptoms experienced by participants and an assessment of their prior knowledge of 
cancer-related symptoms.  Therefore, further studies would benefit from including this 
information.   
 
If disposition traits and illness beliefs could be identified in further research this would 
allow the development of interventions in primary care to address change or influence 
these mechanisms, with the aim of reducing the time taken to seek help.  For routine 
clinical practice, from a psychological perspective, development of knowledge in this 
area would help to identify possible sources of distress for patients post-diagnosis.   
 
The study has highlighted that there are differences between cancer types and 
specifically that individuals with symptoms indicative of colorectal cancer take longer 
to appraise symptoms and seek help.  This in part may be due to the various symptoms 
of colorectal cancer being less identifiable to lay persons, than for example a lump 
possibly indicating breast cancer.  It however, may also be related to the way 
information about colorectal cancer symptoms is provided at a national level to the 
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wider public.  As highlighted, anecdotal evidence indicated that individuals had a poor 
knowledge of colorectal cancer symptoms and were not aware of public health 
information until after they were diagnosed, which they saw in hospital waiting areas.  
This merits further investigation to identify possible methods of communicating 
information about symptoms to the wider public prior to the development of symptoms 
in forums other that medical settings.  Lastly, the identification of relevant dispositional 
traits and illness beliefs would inform the development of educational material and 
future public health interventions to promote early presentation and increase survival 
rates. 
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Figure 1: Andersen’s Model of Total Delay(14) 
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Figure 2:  Principles of Psychophysiological Comparison Processes(17)
 
Assumptions: 
Principle 1: People are motivated to maintain an explicable physiological condition. 
Principle 2: Symptom perception need not to be accurate in terms of physiological 
aetiology. 
Antecedents: 
Principle 3: The strength of the motivation to understand and evaluate one’s 
symptoms is a function of their unexpectedness, salience, personal relevance and 
perceived consequences. 
Psychophysiological Comparisons: 
Principle 4: Symptom interpretation involves a comparison of the symptoms with the 
known consequences of salient situational stimuli (e.g. exposure to pathogens, recent 
medications) and physiological conditions (e.g. allergies, diseases, that is, illness 
prototypes). 
Principle 5: Symptom interpretation is governed in part by logical consistency.  For 
example the probability of a specific illness inference is a direct function of its 
accessibility (familiarity) and an inverse function of the discrepancy between the 
symptoms and the illness prototype. 
Principle 6: Symptom interpretation is governed in part by an optimistic bias.  For 
example innocuous explanations (e.g. prototypes which suggest the symptoms are 
transient or self-correcting) diminish an individual’s motivation to obtain additional 
information or explanations for the condition to a greater degree, ceteris paribus, than 
to threatening explanations.  
Principle 7: The more diffuse the symptoms, the greater the number of potential 
comparisons and consequently, the greater the likelihood of erroneous interpretations 
of the symptoms and the more susceptible to change are the interpretations. 
Effects Of Failing To Find A Comparison: 
Principle 8: If a situational stimulus or illness prototype cannot be initially identified 
to account for the symptoms then the stimuli or prototype(s) which maximizes the 
logical and optimistic bias principles above will be considered.  This will influence 
the subsequent symptom interpretation on two ways: 
(a) The implicit theories people have about stimuli or prototypes will influence the 
attention to and detection of symptoms and the production of symptoms for 
interpretation. 
(b) The particular symptom chosen will influence people’s implicit theories about 
stimuli or prototypes. 
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Table 1: Participant Characteristics by Cancer Site 
 
 Colorectal Cancer (%) N=47 Breast Cancer (%) N=24 
Gender 
Female 40.4  (n=19) 100  (n=24) 
Male 59.6  (n=28) 0  (n=0) 
Age 
Mean Age (SD) 59.68  (10.81) 54.50  (15.69) 
Median 60 51.5 
Range 30-84 26-84 
Socioeconomic Status 
Quintile 1 (Most 
Deprived) 
36.2  (n=17) 8.3  (n=2) 
Quintile 2 17.0  (n=8) 16.7  (n=4) 
Quintile 3 8.5  (n=4) 20.8  (n=5) 
Quintile 4 12.8  (n=6) 20.8  (n=5) 
Quintile 5 (Least 
Deprived) 
25.5  (n=12) 33.3  (n=8) 
 
Table 2: Summary of the Time Taken to Seek Help by Cancer Site 
 
 Colorectal Cancer N=47 Breast Cancer N=24 
Symptom Appraisal 
Mean Number of Days (SD) 76.64  (126.95) 36.96  (62.66) 
Range 0 – 721 0 – 217 
Median 33 8.50 
Action Appraisal 
Mean Number of Days (SD) 10.62  (17.16) 4.46  (7.19) 
Range 0 – 101 0 – 34 
Median 4 2 
Total Time 
Mean Number of Days (SD) 87.26  (131.69) 41.42  (65.068) 
Range 1 – 728 0 – 225 
Median 49 12.5 
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Table 3a: Psychological Outcome Data for Participants with Colorectal Cancer - 
Including Range, Mean, SD, Median, Confidence Interval and Tests of Normality 
 
Measure  Range  Range (present 
study)  
Mean (SD)  Median Skewness 
(Standard 
Error)  
Kurtosis 
(Standard 
Error)  
Kolmogorov-
Smirnov test 
of normality 
(p<0.05)  
LOT-R 0-24 4-24 17.13  (4.68) 17 -0.20  (0.35) -0.26  (0.68) 0.200 
TCI-HA 0 – 35 0-29 10.49  (7.61) 8 0.65  (0.35) -0.51  (0.68) 0.024 
STAI-T 20-80 20-62 33.49  (9.96) 31 1.06  (0.35) 0.72  (0.68) 0.001 
NEO5N 
(T score) 
0-100 26-74 43.45  (10.42) 44 0.45  (0.35) 0.43  (0.68) 0.200 
NEO5O 
(T score) 
0-100 29-64 43.62  (8.26) 45 0.08  (0.35) -0.21  (0.68) 0.200 
NEO5C 
(T score) 
0-100 31-72 54.74  (10.23) 53 -0.09  (0.35) -0.32 (0.68)  0.083 
HADS-A 0-21 0-16 4.98  (4.157) 4 1.09  (0.35) .820  (0.68) 0.001 
HADS-D 0-21 0-13 4.21  (3.432) 3 1.01  (0.35) -.006  (0.68) 0.000 
 
Measures Key: 
LOT-R = Revised Life Orientation Test; TCI-HA = Temperament and Character Inventory–Harm Avoidance scale; STAI-T = State Trait 
Anxiety Inventory–Trait scale; NEO5N = NEO Five-Factor Inventory - Neuroticism scale; NEO5O = NEO Five-Factor Inventory - Openness to 
Experience scale; NEO5C = NEO Five-Factor Inventory - Conscientiousness scale; HADS-A = Hospital Anxiety and Depression Scale – 
Anxiety subscale; HADS-D = Hospital Anxiety and Depression Scale – Depression subscale 
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Table 3b: Psychological Outcome Data for Participants with Breast Cancer -   
Including Range, Mean, SD, Median, Confidence Interval and Tests of Normality 
 
Measure  Range  Range (present 
study)  
Mean (SD)  Median Skewness 
(Standard 
Error)  
Kurtosis 
(Standard 
Error)  
Kolmogorov-
Smirnov test 
of normality 
(p<0.05)  
LOT-R 0-24 8-24 17.42  (4.62) 17.5 -0.33  (0.47) -0.93  (0.92) 0.134 
TCI-HA 0 – 35 0-25 9.50  (7.11) 7.5 0.75  (0.47) -0.38  (0.92) 0.082 
STAI-T 20-80 21-53 32  (8.29) 30 0.82  (0.47) 0.08  (0.92) 0.033 
NEO5N 
(T score) 
0-100 26-64 41.63  (10.08) 40 0.54  (0.47) -0.00  (0.92) 0.175 
NEO5O 
(T score) 
0-100 31-70 47.96  (11.02) 50 0.19  (0.47) -0.73  (0.92) 0.200 
NEO5C 
(T score) 
0-100 36-71 51.96  (8.37) 52 0.30  (0.47) 0.04  (0.92) 0.200 
HADS-A 0-21 0-14 4.17  (4.01) 3.5 1.15  (0.47) 0.66  (0.92) 0.094 
HADS-D 0-21 0-8 2.63  (2.16) 2.5 0.84  (0.47) 0.44  (0.92) 0.182 
 
Measures Key: 
LOT-R = Revised Life Orientation Test; TCI-HA = Temperament and Character Inventory–Harm Avoidance scale; STAI-T = State Trait 
Anxiety Inventory–Trait scale; NEO5N = NEO Five-Factor Inventory - Neuroticism scale; NEO5O = NEO Five-Factor Inventory - Openness to 
Experience scale; NEO5C = NEO Five-Factor Inventory - Conscientiousness scale; HADS-A = Hospital Anxiety and Depression Scale – 
Anxiety subscale; HADS-D = Hospital Anxiety and Depression Scale – Depression subscale 
 
 84 
 
Table 4: Frequency of Scores across Clinical Cut off Data for STAI-T, NEO5 & HADS 
 
 Colorectal Cancer (%) N=47 Breast Cancer (%) N=24 
STAI-T 
Normal (20-39) 74.47  (n=35)  79.17  (n=19)  
Mild (40-55) 21.28  (n=10)  20.83  (n=5)  
Moderate (56-65) 4.26    (n=3) 0         (n=0) 
Severe (65+) 0         (n=0) 0         (n=0) 
NEO5-N 
Low (≤44) 55.31  (n=26)  70.83  (n=17)  
Average (45-55) 34.04  (n=16)  16.67  (n=4)  
High (≥56) 10.64  (n=5) 12.50  (n=3) 
NEO5-O 
Low (≤44) 46.81  (n=22)  37.50  (n=9)  
Average (45-55) 48.94  (n=23)  37.50  (n=9)  
High (≥56) 4.26    (n=2) 25       (n=6) 
NEO5-C 
Low (≤44) 10.64  (n=5) 16.67  (n=4)  
Average (45-55) 48.94  (n=23)  54.17  (n=13)  
High (≥56) 40.43    (n=19) 29.17  (n=7) 
HADS-A 
Normal (0-7) 78.72  (n=37)  83.33  (n=20)  
Borderline (8-10) 12.77  (n=6)  4.17    (n= 1)  
Clinical ‘caseness’ (11+) 8.51    (n=4) 12.50  (n= 3) 
HADS-D 
Normal (0-7) 80.85  (n=38)  95.83  (n=23)  
Borderline (8-10) 12.77  (n=6)  4.17    (n=1)  
Clinical ‘caseness’ (11+) 6.38    (n=3) 0         (n=0) 
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Table 5a: Spearman’s Rho Correlations Between Predictor Variables and Symptom 
Appraisal Time for Breast Cancer Participants 
 
Measure LOT-R NE05-N BIPQ 1 BIPQ 5 BIPQ 6 BIPQ 8 
Symptom Appraisal 
Correlation co-efficient 
 
0.506 
 
0.391 
 
0.499 
 
0.447 
 
0.581 
 
0.528 
Significance (2-tailed) 0.01 0.06 0.01 0.03 0.00 0.01 
 
 
Table 5b: Spearman’s Rho Correlations Between Predictor Variables and Action 
Appraisal Time for Breast Cancer Participants 
 
Measure Age BIPQ 1 BIPQ 8 
Action Appraisal 
Correlation co-efficient 
 
- 0.47 
 
0.466 
 
0.453 
Significance (2-tailed) 0.02 0.02 0.03 
 
 
Table 6: Time to Event Analysis for Age, BIPQ1 and BIPQ8 Predicting Action 
Appraisal Time for Breast Cancer Participants 
 
Variable Hazard Ratio 95% Confidence 
Limits 
P 
Age 1.049 1.010 - 1.089 0.01 
BIPQ1 0.816 0.575 - 1.157 0.25 
BIPQ8 0.986 0.740 - 1.313 0.92 
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Abstract 
Introduction: The experience I identified for reflection was one that caused me to doubt my 
ability to meet the demands of providing consultancy at an organisational level.  I lacked 
confidence in my communication skills and ability to manage difficult interpersonal 
relationships and group dynamics that were evident at a meeting I attended.  This situation 
was identified within the wider context of my training, as there is a logical emphasis on the 
varied skills and roles which, following the completion of my Doctoral training, I will 
continue to develop as I commence my career as a qualified Clinical Psychologist.  The 
experience on which I chose to reflect on was an observation and I outline the two models I 
employed to facilitate and structure my reflection.   
 
Reflection: The reflection is on my observation of a Clinical Managed Network meeting I 
attended, which has relevance to my speciality.  This experience highlighted insecurities I 
had in my ability to communicate psychological principles and promote psychology at a 
higher organisational level.  Equally, it made me aware of the challenges that such a task 
poses, particularly when considering the individual culture of any given institution and any 
internal and external political influences.  Using a structured approach to reflect on this 
incident supported my making sense of the experience and enabled me to identify the 
appropriate learning needs and opportunities to fully develop my skills and confidence in this 
area. 
 
Reflective Review: I reflect on what I have gained from the experience itself and also the 
usefulness of the models I identified to help me do that.  I found that combining two models 
to facilitate my reflection was particularly useful, especially in using this type of approach for 
the first time to reflect.      
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Abstract 
Introduction:  The focus of this reflective account is on my role as a Trainee Clinical 
Psychologist, working effectively within complex systems and supporting the development of 
teams and individuals to enhance performance.  The Clinical Psychology Department I 
currently work in is within a relatively large hospital, which has many services and teams 
within it, which the Department provides input to.  This is a new way of working for me and 
so I chose this aspect of my current placement as the basis of my reflection.  I outline the 
model I used to structure my reflection on a number of incidents, where I had attended multi-
disciplinary team meetings or shadowed other professionals when they were meeting with 
patients at regular clinics. 
   
Reflection:  My reflections on these experiences highlighted to me that I held assumptions 
about what a team was and how Clinical Psychologists should work within them.  Using a 
structured approach to reflect on these experiences facilitated me challenging these 
assumptions, identifying goals for learning and developed my conceptual understanding of 
my role within this area, which has significance for my continued professional development. 
 
Reflective Review:  I outline what I have gained from this process of reflection with regard 
my professional development and current practice and the usefulness of this particular model 
to facilitate this.  I critically appraise the model and summarise my conclusions to facilitate 
further reflections and identify learning goals. 
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Appendix 1.1: Guidelines for Submission to The Breast Journal 
 
 
 
Author Guidelines 
 
Manuscripts will be considered in the form of original articles, breast images, short communications, 
description of techniques, and letters. Submission of a paper implies that it reports unpublished work, 
except in abstract form, and is not being submitted simultaneously to another publication. 
Manuscript submission and specifications 
Manuscripts should be submitted using our online manuscript processing system, ScholarOne.  This 
system may be accessed at http://mc.manuscriptcentral.com/tbj,   If an author is unable to access this 
system, please submit both in hard copy and on disk, to the Editorial office: 
Shahla Masood, MD, Editor 
The Breast Journal 
Department of Pathology 
University of Florida Health Sciences Center 
655 West 8th Street 
Jacksonville, FL 32209-6511 
USA 
 
 
Pre-submission English-language editing 
Authors for whom English is a second language may choose to have their manuscript professionally 
edited before submission to improve the English. A list of independent suppliers of editing services 
can be found at http://authorservies.wiley.com/bauthor/english_language.asp. All services are paid for 
and arranged by the author, and use of one of these services does not guarantee acceptance or 
preference for publication. 
 
 
Copyright Transfer Agreement 
 
Copyright Transfer Agreement - Authors will be required to sign a Copyright Transfer Agreement 
(CTA) for all papers accepted for publication. Signature of the CTA is a condition of publication and 
papers will not be passed to the publisher for production unless a signed form has been received. 
Please note that signature of the Copyright Transfer Agreement does not affect ownership of 
copyright in the material.  (Government employees need to complete the Author Warranty sections, 
although copyright in such cases does not need to be assigned).  After submission authors will retain 
the right to publish their paper in various medium/circumstances (please see the form for further 
details).  To assist authors an appropriate form will be supplied by the editorial office. Alternatively, 
authors may like to download a copy of the form here. 
 
 
Submission on disk 
Disks may be either IBM or MacIntosh compatible. Manuscripts should be prepared preferably using 
the latest versions of Microsoft Word or WordPerfect; alternatively, manuscripts may be saved on disk 
in ASCII format. Please be sure to indicate platform, software name and version number for all disks 
submitted (e.g. IBM Wordperfect, version 6.0). Make sure the file is double-spaced and has no hard 
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returns at the end of lines. Ragged right margins are preferable to justified lines. All textual elements 
should begin flush left with no paragraph indents and two returns after every element, such as titles, 
headings, paragraphs, legends, etc. Please be sure to keep a back up copy of the file for reference 
and safety. Once a manuscript has been accepted, authors will be required to submit a final version 
on disk. 
 
Hard copy 
Three clear copies should be submitted, printed or typed double-spaced on one side of an 8½ x 11 
paper with margins of at least 3 cm. Three copies of any artwork should also be submitted. All pages, 
including tables, must be numbered. All art must be labeled with the author's name, the figure 
number, and the name of the journal. Manuscripts must be submitted exclusively to The Breast 
Journal and will become the copyright of the Publisher. Please submit completed, signed Copyright 
Transfer Agreement with final accepted manuscript. 
 
The first text page should contain: 1. Title; 2. Full names, medical degrees and affiliations of all 
authors; 3. Full postal address for the corresponding author, to whom the proofs will be sent, including 
also telephone, fax numbers, and e-mail for that person; 4. Running title of no more than 45 
characters, including spaces; 5. List of keywords. 
Research papers 
These should be structured as follows: Title page, as above; Abstract; Introduction; Materials and 
Methods; Results; Acknowledgments (optional); References; Tables; Figure legends (double-spaced); 
Figures. 
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Abstracts 
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require abstracts. 
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Appendix 1.2: Methodological Quality Criteria Checklist 
Quality Criteria  0 
points  
1 
point 
2 
points 
1. Does the study have a clearly focused question? 
0 = The aim or hypotheses not clearly stated 
1 = The aim was clearly stated but not hypotheses 
2 = The aim and hypotheses are clearly described  
   
2. Was the inclusion & exclusion criteria clearly defined? 
0 = Not stated 
1 = Referred to but not clearly stated 
2 = Clearly stated 
   
3. Was a power calculation used or sample size justified? 
0 = not completed 
1 =  issues regarding power or sample size acknowledged in introduction/ 
findings or post hoc calculation of power completed but a prior analysis 
not completed/explained 
2 = a prior sample size calculation provided 
   
4. Are the characteristics of the participants included in the study 
clearly described?  
Gender, age, ethnicity/socioeconomic status, stage of cancer  
0 = None of the characteristics stated 
1 = Some of the characteristics stated (1-2) 
2 = All of the characteristics stated (>2) 
   
5. What was the method of selection from the target population?  
0 = Not stated  
1 = Highly selective sample (volunteers / consecutive sample from a 
highly pre-selected group i.e. involved in other study) 
2 = Consecutive sample of convenience / random selection 
   
6. How were psychological factors in response to diagnosis 
measured? 
0 = Self report in an interview only; non-standardised tools 
1 = Mixture of self report in interview and standardised self-report 
tools/interview based on research diagnostic criteria  
2 = Only standardised self-report tools 
   
7. When was the first measurement of psychological variables 
recorded after being informed of diagnosis of breast cancer? 
0 = Not stated; under a month  
1 =  > 6 months after; a large range between participants (from 0 - 
>12mths)   
2 =  < 6 months & similar range for all participants (> 1 - < 6 months after) 
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8. Were there repeated evaluations of the psychological factors over 
a protracted time period? 
0 = No 
1 = >1 - <3  
2 = ≥3 
   
9. What was the length of follow up? 
0 = Only up to a year 
1 = >1year -  <5 (minimum) 
2 = ≥5 (minimum) 
   
10. For survival rates was cancer-specific mortality reported / 
analysed separately from all-cause mortality? 
0 = Not applicable; Not stated or not clearly defined 
1 = Only all-cause mortality reported 
2 = Cancer-specific mortality reported only or as well as all-cause 
   
11. Were known medical & biological (tumor factors) predictive 
variables recorded?  
Size; stage; grade; no. of nodes (stage); estrogen & progesterone 
receptor status; menopausal status; type of treatment 
0 = No confounding variables 
1 = Some medical/biological characteristics stated (≤4) 
2 = More than 4 medical/biological characteristics stated 
   
12. Type of analysis used: 
0 = Not stated; descriptive analysis; univariate analysis only (parametric / 
non-parametric) 
1 = Multivariate: Χ
2
; odds ratio; discrimination analyses or RR reported 
2 = Multivariate: Cox proportional hazards regression model (HR) 
reported 
   
13. Were the identified predictive variables accounted for by 
analysis?  
0 = Analysis not adjusted for predictive variables 
1 = Adjusted for ≤4  predictive variables outlined 
2 = Adjusted for >4 predictive variables outlined 
   
 
 
Total Score: _______________/26______________ 
 
Overall %: ________________________________ 
 95 
 
Appendix 1.3: Full Titles of Assessment Measures Listed in Table 2 
 
HRS Hamilton Rating Scale 
HDHQ Caine and Foulds Hostility and Direction of 
Hostility Questionnaire  
EPI Eysenck Personality Inventory 
RDC Research Diagnostic Criteria 
POMS Profile of Mood States 
DSM-III American Psychiatric Association’s 
Diagnostic and Statistical Manual of Mental 
Disorders – 3rd Edition 
STAI State-Trait Anxiety Inventory 
CECS Courtauld Emotional Control Scale 
SCL-90-R Symptom Checklist-90 – Revised 
PAIS / PAIS-SR Psychosocial Adjustment to Illness Scale / 
Psychosocial Adjustment to Illness Scale – 
Self Report 
BSI Brief Symptom Inventory 
ZQCI Zurich questionnaire of Coping with Illness 
FQCI Freiburg Questionnaire of Coping with 
Illness 
MAC Mental Adjustment to Cancer Scale 
HADS Hospital Anxiety and Depression Scale 
COPE General Coping Strategies Scale 
PAC Psychological Adjustment to Cancer Scale 
IES The Impact of Events Scale 
WOC-CA Ways of Coping Questionnaire – Cancer 
Specific Scale 
AX/Scale Anger Expression Scale 
R/ED Rational/Emotional Defensiveness 
DEPS The Depression Scale 
WCC-R Ways of Coping Checklist - Revised 
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Appendix 2.1: Guidelines for submission to Psycho-Oncology 
 
 
 
Author Guidelines 
 
Manuscript Submission 
All papers must be submitted via the online system. 
Psycho-Oncology operates an online submission and peer review system that allows authors to 
submit articles online and track their progress via a web interface.  
 
Please read the remainder of these instructions to authors and then click 
http://mc.manuscriptcentral.com/pon to navigate to the Psycho-Oncology online submission site, 
ScholarOne Manuscripts (formerly known as Manuscript Central). IMPORTANT: Please check 
whether you already have an account in the system before trying to create a new one. If you have 
reviewed or authored for the journal in the past year it is likely that you will have had an account 
created. 
File types. Preferred formats for the text and tables of your manuscript are .doc, .rtf, .ppt, .xls. LaTeX 
files may be submitted provided that an .eps or .pdf file is provided in addition to the source files. 
Figures may be provided in .tiff or .eps format. 
Please note: This journal does not accept Microsoft Word 2007 documents at this time. Please use 
Word's "Save As" option to save your document as a .doc file type. If you try to upload a Word 2007 
document in ScholarOne Manuscripts you will be prompted to save .docx files as .doc files. 
Initial Submission 
Non-LaTeX Users: Upload your manuscript files. At this stage, further source files do not need to be 
uploaded. 
LaTeX Users: For reviewing purposes you should upload a single .pdf that you have generated from 
your source files. You must use the File Designation "Main Document" from the dropdown box. 
Revision Submission 
Non-LaTeX Users: Editable source files must be uploaded at this stage. Tables must be on separate 
pages after the reference list, and not be incorporated into the main text. Figures should be uploaded 
as separate figure files. 
LaTeX Users: When submitting your revision you must still upload a single .pdf that you have 
generated from your now revised source files. You must use the File Designation "Main Document" 
from the dropdown box. In addition you must upload your TeX source files. For all your source files 
you must use the File Designation "Supplemental Material not for review". Previous versions of 
uploaded documents must be deleted. If your manuscript is accepted for publication we will use the 
files you upload to typeset your article within a totally digital workflow. 
Copyright and Permissions 
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Authors must sign, scan and upload to the online system: 
 a Copyright Transfer Agreement with original signature(s) - without this we are unable to accept 
the submission, and 
 permission grants - if the manuscript contains extracts, including illustrations, from other copyright 
works (including material from on-line or intranet sources) it is the author's responsibility to obtain 
written permission from the owners of the publishing rights to reproduce such extracts using the 
Wiley Permission Request Form . 
The Copyright Transfer Form and the Permissions Form should be uploaded as “Supplementary files 
not for review” with the online submission of your article. 
 
If you do not have access to a scanner, further instructions will be given to you after acceptance of the 
manuscript. 
To enable the publisher to disseminate the author's work to the fullest extent, the author must sign a 
Copyright Transfer Agreement , transferring copyright in the article from the author to the publisher, 
and submit the original signed agreement with the article presented for publication. A copy of the 
agreement to be used (which may be photocopied) can be found in the first issue of the year on the 
Wiley InterScience website and through links in the online submission system. Copies may also be 
obtained from the journal editors or publisher. 
Submission of a manuscript will be held to imply that it contains original unpublished work and is not 
being submitted for publication elsewhere at the same time. Submitted material will not be returned to 
the author, unless specifically requested. 
 
Manuscript style. The language of the journal is English. 12-point type in one of the standard fonts: 
Times, Helvetica, or Courier is preferred. It is not necessary to double-line space your manuscript. 
There should be a separate title page with full information and another page for an abstract, prior to 
the Introduction. Tables must be on separate pages after the reference list, and not be incorporated 
into the main text. Figures should be uploaded as separate figure files. 
 During the submission process you must enter the full title, short title of up to 70 characters and 
names and affiliations of all authors. Give the full address, including email, telephone and fax, of 
the author who is to check the proofs. 
 Include the name(s) of any sponsor(s) of the research contained in the paper, along with grant 
number(s). 
 Enter an abstract of up to 250 words for all articles. An abstract is a concise summary of the 
whole paper, not just the conclusions, and is understandable without reference to the rest of the 
paper. It should contain no citation to other published work. Submit your abstract according to 
these headings: objective; methods; results; conclusions. 
 Include up to six keywords which must contain the words cancer and oncology that describe 
your paper for indexing purposes. 
 Research Articles should not exceed 4500 words (including figures and/or tables but excluding 
references). The limit for Brief Reports is 2000 words including no more than two tables or figures 
and no more than 20 references. 
All abbreviations except for SI symbols should be written in full the first time they appear. Generic or 
clinical names should be used for all compounds: materials and products should be identified. The 
species of any animals used should be stated precisely. Sources of unusual materials and chemicals, 
and the manufacturer and model of equipment should be indicated. materials and products should be 
identified in the text followed by the trade name in brackets. 
Reference style .References should be cited in the text by number within square brackets and listed 
at the end of the paper in the order in which they appear in the text. All references must be complete 
and accurate. If necessary, cite unpublished or personal work in the text but do not include it in the 
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reference list. Where possible the DOI for the reference should be included at the end of the 
reference. Online citations should include date of access. References should be listed in the following 
style: 
Decker, CL. Social support and adolescent cancer survivors: A review of the literature. Psycho-Oncol 
2007; 16 : 1-11. 
Peterson AC, Leffert N. What is special about adolescence? In Psychosocial Disturbances in Young 
People: Challenges for Prevention, Rutter M (ed.).Cambridge University Press: Cambridge, 1997;3-
36. 
Illustrations. Upload each figure as a separate file in either .tiff or .eps format, with the figure number 
and the top of the figure indicated. Compound figures e.g. 1a, b, c should be uploaded as one figure. 
Tints are not acceptable. Lettering must be of a reasonable size that would still be clearly legible upon 
reduction, and consistent within each figure and set of figures. Where a key to symbols is required, 
please include this in the artwork itself, not in the figure legend. All illustrations must be supplied at 
the correct resolution: 
Black and white and colour photos - 300 dpi 
Graphs, drawings, etc - 800 dpi preferred; 600 dpi minimum 
Combinations of photos and drawings (black and white and colour) - 500 dpi 
Tables should be part of the the main document and should be placed after the references. If the 
table is created in excel the file should be uploaded separately. 
Colour Policy. Where colour is necessary to the understanding of the figures, colour illustrations will 
be reproduced in the journal without charge to the author, at the Editor's discretion. 
Post Acceptance 
Further Information. For accepted manuscripts the publisher will supply proofs to the submitting 
author prior to publication. This stage is to be used only to correct errors that may have been 
introduced during the production process. Prompt return of the corrected proofs, preferably within two 
days of receipt, will minimise the risk of the paper being held over to a later issue. Free access to the 
final PDF offprint of your article will be available via Author Services only. Please therefore sign up for 
Author Services if you would like to access your article PDF offprint and enjoy the many benefits the 
service offers. 
Authors Resources: Manuscript now accepted for publication? 
If so, check out our suite of tools and services for authors and sign up for: 
Article Tracking 
E-mail Publication Alerts 
Personalization Tools 
Cite EarlyView Articles 
To link to an article from the author’s homepage, take the DOI (digital object identifier) and append it 
to "http://dx.doi.org/" as per following example: 
DOI 10.1002/hep.20941, becomes http://dx.doi.org/10.1002/hep.20941. 
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To include the DOI in a citation to an article, simply append it to the reference as in the following 
example: 
 
Oestreicher, N., The cost of adjuvant chemotherapy in patients with early-stage breast carcinoma, 
Cancer 10(1), pp. 2054 - 2062, DOI: 10.1002/cncr.21464. 
Online Open 
OnlineOpen is available to authors of primary research articles who wish to make their article 
available to non-subscribers on publication, or whose funding agency requires grantees to archive the 
final version of their article. With OnlineOpen, the author, the author's funding agency, or the author's 
institution pays a fee to ensure that the article is made available to non-subscribers upon publication 
via Wiley InterScience, as well as deposited in the funding agency's preferred archive. For the full list 
of terms and conditions, see 
http://www3.interscience.wiley.com/authorresources/onlineopen.html#OnlineOpen_Terms. 
Any authors wishing to send their paper OnlineOpen will be required to complete the payment form 
available from our website at: https://secure.interscience.wiley.com/funded_access.html 
Prior to acceptance there is no requirement to inform an Editorial Office that you intend to publish 
your paper OnlineOpen if you do not wish to. All OnlineOpen articles are treated in the same way as 
any other article. They go through the journal's standard peer-review process and will be accepted or 
rejected based on their own merit. 
Note to NIH Grantees 
Pursuant to NIH mandate, Wiley-Blackwell will post accepted version of contributions authored by NIH 
grant-holders to PubMed Central upon acceptance. This accepted version will be made publicly 
available 12 months after publication. For further information, see www.wiley.com/go/nihmandate 
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Abstract 
 
The time taken to seek help has been highlighted as a key component in improving prognosis 
for cancer patients.  Delay in help-seeking refers to the period between an individual’s first 
awareness of a symptom of illness and initial medical consultation.  This process is seen to be 
multifaceted, possibly influenced by a person’s knowledge of the disease, their interpretation 
of symptoms and attitude towards professional care.  These appraisals and decisions may be 
influenced by psychological factors.  The aim of this study is to investigate possible 
individual differences and the time taken to seek help for individuals with colorectal or breast 
cancer.   
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Introduction 
 
The Scottish Government have identified early reporting of symptoms as a key component of 
successful cancer management
1
.  Untreated cancer advances in stage, diminishing the 
chances of survival
2
.  Treatment of cancer at an early stage improves the prospects for long 
term survival.  Evidence from data gathered from the Enhanced Service for Cancer Referrals 
by the Scottish Primary Care Cancer Group, indicates that patients frequently have symptoms 
for a considerable period of time before seeking help
1
.  Delay ranged from 30 to 80 days 
depending on cancer type
1
.  Therefore, an understanding of the factors that determine the 
timing of treatment remains of paramount importance.     
 
Levy has noted that colon and breast cancer have better prognosis if detected at an early 
stage
3
.  These types of cancer often have more salient identifiable symptoms to the lay 
person, such as rectal bleeding in colorectal cancer and a lump in the breast area, in breast 
cancer.  Therefore these cancer types will be the focus of this study.   
 
Breast Cancer 
Breast cancer is the most commonly diagnosed cancer in women in Scotland
1
.  A systematic 
review of observational studies examining the association between survival and the time from 
onset of symptoms until the commencement of treatment found delays of more than 12 weeks 
were associated with poorer survival rates
4
.  There were three categories of data from the 
studies identified.  Studies of five year survival data showed patients with delays of three 
months or more  had 12% lower 5 year survival compared to those with delays of less than 
three months
4
.  Also longer delays were associated with a more advanced stage and when the 
effect of stage was controlled for, delay was not associated with poorer survival
4
. 
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Colorectal Cancer 
Scotland has one of the highest incidences of colorectal cancer in the world
5
.  Survival rates 
in the UK are poorer than in Europe
6
.  The Eurocare study supports the view that this has 
mainly been due to late diagnosis, leading to high emergency rates
7
.  Differences in long-term 
survival appear to be a result of differences in death-rates in the first six months after 
diagnosis; being highest in places where patients were most likely to be treated as 
emergencies
7
.   Countries in which, patients survived longer had a higher proportion of early-
stage tumours and were more likely to undergo elective surgery
8
.  This indicates that a major 
factor in survival is disease stage.  Studies in the UK have shown that rectal bleeding is 
commonly experienced although over half of those experiencing it do not seek 
consultation
9,10
. 
 
Reasons for Delay in Help-seeking 
An understanding of the factors, which influence patient’s delaying to seek help, is a 
prerequisite for the development of strategies to shorten delays.  A number of different 
factors have been considered in investigating the reason for delay in help-seeking.  Both 
demographic and psychological factors are associated with delay in seeking medical help
11
.  
Demographic variables associated with delay include lower education and socioeconomic 
status, older age, and being from an ethnic minority group
12
.  Psychological factors such as 
severe anxiety and beliefs about prognosis have been associated with treatment delay, while 
low levels of initial emotional distress are associated with treatment delay in others
13
.   The 
processes that are required to be completed before help can be sought are seen to be 
multifaceted, possibly influenced by a person’s knowledge of the disease and their 
interpretation of symptoms and attitude towards professional care.  An area that has received 
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less attention and may mediate these factors are individual differences such as personality 
constructs. 
 
Delay Stages and Psychophysiological Comparison Processes 
Andersen and colleagues presented a model of ‘total delay’, which describes the time 
between an individual first noticing a symptom until they receive treatment.  The model 
comprises five dichotomous stages (appraisal, illness, behavioural, scheduling and treatment 
delay), which facilitate the investigation of factors that contribute to delay at each stage
14
.  
Each stage is governed by distinct appraisals, decisions and actions.  Appraisal delay 
constitutes the time between first noticing the symptom and appraising it as serious.  Illness 
delay includes the time from appraising the symptom as serious until deciding to seek 
medical help.  Behavioural delay is the time between making the decision to seek help and 
actually making an appointment.  The time between seeking a first appointment and the first 
consultation is scheduling delay.  Treatment delay is the time lapse between first consultation 
and commencing treatment.  The first three stages are influenced by patient delay, while 
scheduling and treatment delay can be influenced by both patient delay and professional 
delay. The majority of delay is accounted for by patient delay
14
. 
 
Research indicates that appraisal delay usually accounts for the longest portion of patient 
delay
15,16
.  Therefore, the psychological processes involved during this period are of 
particular interest.  Andersen et al (1990)
17
 developed a general attributional framework 
outlining the psychological processes governing the detection of symptoms and illness 
inferences, which may impact on appraisal delay.  Psychophysiological Comparison Theory 
incorporates eight principles proposed to govern symptom appraisal
14
.  The process is 
conceptualised as one of psychophysiological comparison (Figure 1) and is often biased to 
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support a positive view of the individual’s physiological condition.  Therefore, there is a 
possible role for personality factors to contribute to this process as well as illness cognitions, 
which refer to an individual’s perception and understanding of their experience of a specific 
disease and may impact on their coping responses
18
. 
 
Figure 1:  Principles of Psychophysiological Comparison Processes
14 
Assumptions: 
Principle 1: People are motivated to maintain an explicable physiological condition. 
Principle 2: Symptom perception need not to be accurate in terms of physiological aetiology. 
Antecedents: 
Principle 3: The strength of the motivation to understand and evaluate one’s symptoms is a 
function of their unexpectedness, salience, personal relevance and perceived consequences. 
Psychophysiological Comparisons: 
Principle 4: Symptom interpretation involves a comparison of the symptoms with the known 
consequences of salient situational stimuli (e.g. exposure to pathogens, recent medications) 
and physiological conditions (e.g. allergies, diseases, that is, illness prototypes). 
Principle 5: Symptom interpretation is governed in part by logical consistency.  For example 
the probability of a specific illness inference is a direct function of its accessibility 
(familiarity) and an inverse function of the discrepancy between the symptoms and the illness 
prototype. 
Principle 6: Symptom interpretation is governed in part by an optimistic bias.  For example 
innocuous explanations (e.g. prototypes which suggest the symptoms are transient or self-
correcting) diminish an individual’s motivation to obtain additional information or 
explanations for the condition to a greater degree, ceteris paribus, than to threatening 
explanations.  
Principle 7: The more diffuse the symptoms, the greater the number of potential comparisons 
and consequently, the greater the likelihood of erroneous interpretations of the symptoms and 
the more susceptible to change are the interpretations. 
Effects Of Failing To Find A Comparison: 
Principle 8: If a situational stimulus or illness prototype cannot be initially identified to 
account for the symptoms then the stimuli or prototype(s) which maximizes the logical and 
optimistic bias principles above will be considered.  This will influence the subsequent 
symptom interpretation on two ways: 
(c) The implicit theories people have about stimuli or prototypes will influence the attention 
to and detection of symptoms and the production of symptoms for interpretation. 
(d) The particular symptom chosen will influence people’s implicit theories about stimuli or 
prototypes. 
 
 
 106 
 
Individual Differences & Delay in Help Seeking 
Although there has been extensive research in the area of personality traits and health 
behaviours there has been limited research into their role in relation to patients with cancer 
help seeking
19
.  Ristvedt & Trinkaus investigated the association between patient delay in 
rectal cancer and ‘Trait anxiety’16.  They adopted this term to describe the psychological 
dimension that correlates with the occurrence of ‘somatic concern’ as it has been 
conceptualised in different ways by various researchers, using terms such as ‘neuroticism’ 
and ‘negative affectivity’16.  This dispositional trait is manifested in the degree of tendency 
towards anxiety, worry and negative emotions in general
16
.  They identified two stages of 
patient delay using Andersen’s model14: ‘appraisal delay’ and ‘action delay’; which 
combined illness and behavioural delay.  They examined whether a low Trait Anxiety was 
associated with longer symptom appraisal times and if there was any association with action 
appraisal times.    
 
Sixty nine participants took part in the questionnaire study.  Trait Anxiety was measured by 
the Temperament and Character Inventory Harm Avoidance Scale (TCI - HA)
20
 and 
Spielberger State Trait Anxiety Inventory – Trait Anxiety Scale (STAI-T)21.  Individuals 
scoring lowly on the TCI-HA are characterised as relaxed and optimistic.  Cox proportional 
hazards analysis was used to examine if symptom appraisal time was associated with these 
measures. 
 
There was a significant finding for the TCI-HA.  Longer symptom appraisal time was 
associated with low scores on the TCI – HA (chi-square = 15.50; p = 0.0084; df = 5), while 
significance was not met using the STAI – T (chi-square = 10.80; p = 0.0556; df = 5).  They 
concluded that individuals with a dispositional insensitivity to threat had longer appraisal 
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times.  They postulated that the reason for this difference between the measures was that the 
STAI-T includes cognitive and somatic aspects of anxiety, while the TCI-HA only focuses on 
cognitive aspects of anxiety.   However, it is also plausible that the construct of optimism was 
influencing the discrepancy between these two measures, as individuals scoring lowly on the 
TCI-HA are characterised as optimistic.  They found no associations for either measure with 
action appraisal time. 
 
Individual Differences & Health Related Behaviour 
People with a highly optimistic life orientation tend to hold more positive expectancies for 
their future than pessimists
22
.  There is evidence that a positive life orientation is beneficial to 
health and has been associated with better recovery after a serious illness.  The effect of 
dispositional optimism on recovery from coronary artery bypass surgery was examined in a 
group of middle-aged men
23
.  Optimism was assessed prior to surgery and it correlated 
positively with manifestations of problem-focused coping.  It was associated with a faster rate 
of physical recovery during hospitalization, a faster rate of return to normal life activities 
after discharge and with better postsurgical quality of life at six months
23
.  A longitudinal 
study assessing patients with early stage breast cancer found that dispositional optimism is 
inversely related to level of distress prior to and after surgery up to a year later
24
.  Analysis 
suggested that optimism was mediated by the use of different coping strategies, such as 
engaging in acceptance and not engaging in behavioural disengagement
24
.  A general 
characterization of the findings of this research is that optimists tend to use more problem-
focused coping strategies than do pessimists
22
.  Optimism has also been examined in relation 
to preventive health behavior such as breast self-examination, finding that optimism among 
other predictors derived from the Health Belief Model was related to the frequency of breast 
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self-examination
25
.  Variables in this model accounted for about 37% of the variance in breast 
self-examination
25
.  
 
Therefore, when considering action appraisal time it is likely that optimistic individuals will 
engage in more adaptive health behaviours, such as seeking help sooner as they may be more 
optimistic about the final outcome if early action is taken.  However, when considering 
appraisal delay Andersen and colleagues
14
 propose that during symptom appraisal the process 
of comparison is governed by an optimistic bias (Principle 6).  That is an individual is more 
likely to generate an innocuous cause for new symptoms rather than attribute it to a serious 
illness.  This may have a negative impact on health if it delays help seeking as a result of 
symptoms being attributed to a less serious, transient self-correcting cause.  Therefore, it 
would be predicted that individuals with higher optimism would have longer symptom 
appraisal times as they may be more likely to generate innocuous explanations for their 
symptoms.  Consequently, it would be important to investigate if optimism has an impact on 
the time taken to seek help at each of these stages. 
 
Another personality construct not previously addressed is conscientiousness.  
Conscientiousness is defined as a dispositional tendency to be prudent, planful, persistent 
(and) dependable
26
.  There appear to be links between conscientiousness and pathways to 
good health behaviours and adherence with medical advice
19,26
.  Jerram and Coleman
19 
found 
an association between conscientiousness and more positive health perceptions and visits to 
the GP in older males.  It is therefore likely that conscientious individuals may engage in 
more adaptive health coping strategies when confronted with health stressors.  This may 
facilitate shorter action appraisal times.   
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Another potentially relevant personality trait is openness to experience.  Jerrman and 
Coleman found an association with positive health perceptions for an older population
19
.  
High scores on the openness to experience scale have also been linked with the ability to 
notice new events and put new interpretations on observations
19
.  Therefore, in relation to 
engaging in seeking help for serious symptoms there may be an inverse association between 
openness to experience and symptom appraisal time.  
 
The Psychophysiological Comparison theory highlights that the implicit theories individuals 
have about a particular illness will influence their attention to symptoms and the appraisal 
process
14
.  Grunfeld and colleagues examined age and socio-economic variations in relation 
to knowledge and beliefs about breast cancer among a sample of the general female 
population
27
.  The findings indicated that although this was more significant for older woman 
all age groups had limited knowledge of their relative risk of developing breast cancer, of 
associated risk factors and of the diversity of potential breast cancer-related symptoms.  It 
would therefore appear prudent to consider illness perceptions when considering individual 
differences.  The principal theoretical framework is the self-regulation model developed by 
Leventhal and colleagues, which describes the process by which individuals respond to a 
perceived health threat
18
.  The model proposes that the detection of symptoms generate both 
cognitive and emotional representations of an illness, which can be highly idiosyncratic.  
Symptom perceptions and health beliefs has previously been examined as predictors of 
intentions to seek medical help in a female population for breast cancer
28
.  Analysis revealed 
that the cognitive component of the self-regulation model accounted for approximately 22% 
of the variance in help-seeking intention, which further supports the importance of 
considering illness representations
28
.  
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2. Aims and hypotheses 
 
Aims 
The primary aim is to examine the association between personality factors and the time taken 
to appraise and then seek professional advice, on discovery of symptoms indicative of cancer 
in individuals diagnosed with cancer. 
 
A secondary aim is to examine the association between illness representations and the length 
of time taken to engage in help-seeking behaviour in individuals diagnosed with cancer. 
 
A further secondary aim is to replicate the findings of the Ristvedt & Trinkaus
16
 study and 
examine if the differences between the TCI-HA & STAI-T are repeated.  
 
Primary Hypotheses 
 A low level of ‘trait anxiety’ or neuroticism as measured by the TCI – HA scale, the 
STAI-T and NEO Five-Factor Inventory (NEO-FFI)
29
 will be associated with longer 
symptom appraisal time and shorter action times. 
 High optimism will be associated with longer symptom appraisal times and shorter action 
appraisal times.     
 Conscientiousness will be associated with shorter Action Appraisal times. 
 Openness to experience will be associated with shorter Symptom Appraisal times.  
 
3. Plan of Investigation 
 
Participants 
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 Individuals commencing treatment for breast cancer or colorectal cancer.  It was decided 
to include individuals who had a diagnosis of cancer rather than individuals who were 
uncertain of their diagnosis as this will provide some time for the individual to adjust to 
the diagnosis. 
 
Inclusion and Exclusion Criteria 
 Inclusion criteria:  
 Participants will be aged 18 years or over as some of the measures have been 
standardised for this age-group.  There is no upper age limit. 
 Participants will be English speaking.  
 Exclusion criteria: 
 Individuals whose symptoms were detected by a third party such as a medical 
health care provider, independent of self-discovery of the symptoms will be 
excluded as there is no opportunity for these individuals to seek help or delay and 
so measures of appraisal and illness delay will be unable to be measured and 
analysed.  However, the demographic information for these individuals will be 
analysed. 
 Participants who have received treatment previously for any cancer type will be 
excluded.  However, future research should extend this study to assess time taken 
to seek help for this population. 
 Participants will be excluded on the basis of any cognitive impairment or learning 
disability, which may impact on ability to understand and complete measures or 
reliable recall stages of delay in help-seeking process.   
 
Recruitment Procedures 
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 Participants will be recruited from the Beatson West of Scotland Cancer Centre 
(BWoSCC).  Consultants will be briefed on the objectives of the study and an outline of 
the inclusion and exclusion criteria.  All individuals, who meet the inclusion criteria, will 
be invited to participate in the study. 
 The consultant will introduce the study to patients during their second clinic appointment, 
using an information sheet inviting them to participate in the study.  Individuals who 
would like further information will have the opportunity to meet with the researcher and 
discuss the study.  Individuals will be given time to consider if they would like to 
participate in the study and provided with a copy of the information sheet.  If they decide 
that they would like to participate they will be provided with a consent form and 
commence with the study. 
   
Measures 
 To provide an objective measure of delay the stage of cancer will be recorded.  This will 
provide an indication of how long an individual has had cancer for.  Permission will need 
to be sought to access participants’ medical files to record this information.   
 Demographic information (sex; age; geographical area; education level) will also be 
recorded.  The Scottish Index of Multiple Deprivation (SIMD) will be calculated using 
the participants’ postcode30.  
 The following self report measures will be completed: 
 
1. An estimate of the time taken to seek help will be measured by interviewing 
participants utilising the approach proposed by Andersen and colleagues to measure 
delay by identifying the first three sequential stages involved in help seeking
14
.   
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The nature of this study means that it is subject to recall bias and error as it is relying 
on retrospective reports.  It is possible that there will be a recall bias as participants 
try to account for their past actions with respect to their current diagnosis.  However, 
qualitative data in a study of reasons for delay in seeking help by participants 
diagnosed with lung cancer indicated that there was no evidence of this as they did 
not have a good knowledge of the connections between health changes and lung 
cancer
31
.  The literature indicates that there is significant variability in recall of illness 
related information over time in physical health settings
32,33
.  As the timing of data 
collection is extremely important it will be completed as close to the actual 
occurrence of symptoms within the limits of this study to minimise recall bias while 
allowing for initial adjustment to this life event.  Previous research indicates that the 
emotional response to a diagnosis of cancer does not impact significantly on the 
accuracy of recall
14
.      
 
An assessment of delay in stages will be calculated in days.  The researcher will 
interview the participant using a calendar to assist recall and complete the record 
sheet (Appendix 1).  Prompt questions will be utilised to facilitate recall and cues 
employed as anchoring events.   An outline of prompt questions and possible cues are 
outlined: 
 Appraisal Delay: 
 What symptom(s) did you detect? 
 When did you first become aware of your symptom(s)? 
 What time of year was it i.e. before or after (cue)? 
 How long after you noticed your first symptom did you decide it may be 
something serious? 
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 Illness delay  
 How much time passed before you decided to seek medical help? 
 What other significant events where happening at that time? 
 Did you decide to seek help before or after (cue)? 
 Behavioural Delay 
 How long did you wait before making an appointment to see your GP for 
those symptoms? 
 Can you remember what you were doing that day?  
 
2. Temperament and Character Inventory (TCI)– Harm Avoidance Scale (HA)20 
 The short self-report form will be used.  The TCI - HA scale measures individual 
differences in sensitivity to signals of possible threat, danger or punishment.   
 
3. Spielberger State Trait Anxiety Inventory – Trait Anxiety Scale (STAI-T)21 
 The STAI-T consists of twenty statements, which indicate the degree of habitual 
anxiety. 
 
4. NEO Five-Factor Inventory (NEO-FFI)29 
 The NEO-FFI is a shortened version of the Revised NEO Personality Inventory 
(NEO PI-R)
34
.  There are 60 items rated on a five point scale, based on the Five 
Factor Model.  It will be used to measure Conscientiousness, Neuroticism, and 
Openness to Experience as there is some evidence that these three factors may be 
associated with time taken to seek help. 
 
5. Revised Life Orientation Test (LOT–R)22 
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The LOT-R was used to assess individual differences in generalized optimism 
(Appendix 2).  It consists of ten items and higher values indicate higher levels of 
optimism.  
 
6. The Brief Illness Perception Questionnaire (Brief IPQ)35 
 Consists of nine-items using a ten point Likert scale designed to assess the 
cognitive and emotional representations of illness proposed in Leventhal's self-
regulatory model. 
 
7. Hospital Anxiety and Depression Scale (HADS)36 
 This is a self screening questionnaire to detect the presence and severity of 
depression and anxiety in a medical population.  This is included to assess 
confounding variables that may impact on recall. 
 
Design 
 The study will use a cross-sectional correlational design. 
 
Research Procedures 
 Consent forms will be completed if individuals wish to participate. 
 Demographic information (sex; age; geographical area; education level) will be recorded. 
 Participants will be asked to complete the six measures and questionnaire.   
 The time taken to complete these measures should be approximately 60 minutes. 
    
Justification of sample size 
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 Sample size was calculated according to the procedures required when regression analysis 
is to be applied to the data
37
.  The calculation involves four input parameters: (1) alpha 
(probability) level; (2) number of predictors; (3) anticipated effect size; (4) desired 
statistical power level.   
 Unfortunately, there are no relevant effects sizes reported in the literature from which to 
estimate the effect in the present study.   By convention in such situations, therefore, the 
assumption was made of a medium effect size of 0.15.  Power was set at 0.80 and alpha at 
0.05.   
 The independent (predictor) variables are those derived from the psychological 
assessments outlined above.  They are as follows: (1) personality variables of 
Conscientiousness, Neuroticism, and Openness to Experience (NEO Five Factor 
Personality Inventory); (2) Optimism (Revised Life Orientation Test); (3) Illness Beliefs 
(Brief Illness Perception Questionnaire); (4) Harm Avoidance (Temperament and 
Character Inventory); (5) Trait Anxiety  (State-Trait Anxiety Inventory).  In addition, 
analysis will determine whether socio-economic status (DEPCAT) influences the 
dependent variable in light of evidence that those of lower socio-economic status are 
more likely to delay presentation.  Equally, the relationship between current 
symptomatology and the variables will be analysed to assess the impact of this on recall.  
As there is likely to be co-linearity between Neuroticism, Harm Avoidance and Trait 
Anxiety these variables will be unable to be entered simultaneously into the regression.   
 With predictors as above, the calculation based on seven probable non-correlated 
predictor variables estimates that the required sample size to test the hypotheses is 103 
participants.  This was calculated using an online power calculator G*power
38
. 
 
Data Analysis 
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 The Statistical Package for Social Sciences (SPSS) will be used to store and analyse the 
data.  To ensure confidentiality of participant information, participants will be identified 
by a unique code for storage of information.  
 Participant characteristics will be defined using descriptive statistics.  Prior to formal 
analysis data will be checked for skewness and kurtosis.  As a prelude to the regression 
analysis, correlational analysis will be conducted between the dependent and independent 
variables and between the independent variables.  This is to detect co-linearity between 
the independent variables.  Then a regression analysis will be applied to assess the 
association between the independent and dependent variables.   
 The independent variables are Conscientiousness, Neuroticism, and Openness to 
Experience scales on the NEO-FFI; Optimism as measured by LOT-R, illness 
representations as measured by the IPQ-R, Trait Anxiety as measured by the TCI-HA 
scale and STAI-T, presence of current symptomatology as measured by the HADS and 
demographic information.  As there is likely to be co-linearity between neuroticism and 
Trait Anxiety these variables will be unable to be entered simultaneously into the 
regression.  Therefore, there will be a total of seven variables used in the regression 
analysis.  The dependent variable is the time in days from first recognizing the symptoms 
to seeking medical help. 
 As a secondary outcome measure time-to-event analysis will be will be completed using 
Cox proportional hazard analysis to assess whether symptom appraisal time and action 
appraisal time are associated with scores on the measures of personality constructs.  The 
event of interest in symptom appraisal is the point when the individual becomes aware of 
the seriousness of their symptoms but some participants will not appraise their symptoms 
as serious before seeking a medical consultation.  Time to event analysis allows inclusion 
of data for those participants where the event of interest is not observed. 
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Settings and Equipment 
The study will be carried out in a quiet room at the BWoSCC.  It will require no special 
equipment other than the measures and questionnaire.  The HADS, NEO-FFI, IPQ-R and 
STAI-T are readily available in the Department of Psychological Medicine.  The LOT-R is 
available freely but the TCI will have to be purchased. 
 
4. Health and Safety Issues 
 
 Participants will be seen at the BWoSCC, during working hours and medical health 
professionals will be in close proximity in case of emergency. 
 
5. Ethical Issues 
 
 Ethics approval will be sought from the BWoSCC In-House Trials Advisory Board 
(IHTAB) and the Greater Glasgow Primary Care NHS Trust Research Ethics Committee 
before the study is carried out.  Participants may be experiencing distress as a result of 
recently receiving a diagnosis of cancer and as part of routine procedures will be 
monitored for levels of distress by the responsible team.  The psychological assessments 
proposed are used routinely and there is no evidence that these cause harm or distress.  
The questionnaire used to assess the time taken to seek help focuses on progression of 
events rather than emotional aspects of the process.  However, if an individual did 
experience distress in recalling events that occurred prior to consultation with a health 
care professional the researcher is a Trainee Clinical Psychologist and is trained to 
provide immediate support to the individual.  If there is evidence of any psychological 
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issues these will be highlighted to the responsible Consultant and referral made to the 
Psychology Service at the BWoSCC as necessary.      
 
6. Financial Issues 
 
  The TCI will have to be purchased.     
 
7. Timetable 
 
 After receiving ethics approval I will proceed with data collection at the end of January 
2010.  Individuals will be recruited within a four month period.  Data will be analysed in 
May 2010. 
 
8. Practical Applications 
 
 The problem of ‘delay’ in diagnosing cancer as a result of late presentation to a health 
professional by the individual experiencing symptoms has been highlighted as part of 
broader initiatives to reduce mortality rates as a result of cancer.  Cancer Research UK 
has indicated that their main aim is to reduce mortality and that reducing delay is one of 
the primary areas of their focus
39
.  Although the psychological characteristics being 
investigated in this study are not easily amenable to change, they could provide direction 
for identifying groups at the greatest risk for misinterpreting cancer symptomatology and 
delay.  The Scottish Primary Care Cancer Group advised that public education 
programmes on common cancer symptoms should be developed and disseminated to 
encourage patients to present early
40
.  Identifying characteristics of at risk populations 
would have implications for the development of educational material, future public health 
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initiatives and would inform practice.  This could reduce delay time and increase survival 
rates.   
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Appendix 1: Overview of Time Taken To Seek Help 
 
 
1. First became aware of symptom(s):  ___/___/____ 
Decided symptom(s) may be serious:  ___/___/____       Symptom Appraisal:  _____ days 
2. First decided to seek medical help: ___/___/____             Illness Delay:           _____ days 
3. Arranged an appointment:  ___/___/____                          Behavioural Delay: _____ days 
             Action Appraisal:        _____ days 
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Appendix 2: Life Orientation Test - Revised 
 
Please be as honest and accurate as you can throughout. Try not to let your response to one statement influence your responses 
to other statements.  There are no “correct” or “incorrect” answers.  Answer according to your own feelings, rather than how you 
think “most people” would answer. 
 
 I agree a 
lot 
I agree a 
little 
I neither 
agree or 
disagree 
I disagree 
a little 
I disagree 
a lot 
1. In uncertain times, I usually expect the best. 
     
2. It’s easy for me to relax. 
     
3. If something can go wrong for me, it will. 
     
4. I’m always optimistic about my future. 
     
5. I enjoy my friends a lot. 
     
6. It’s important for me to keep busy. 
     
7. I hardly ever expect things to go my way. 
     
8. I don’t get upset too easily. 
     
9. I rarely count on good things happening to me. 
     
10. Overall, I expect more good things to happen to me than bad.  
     
            
Scheier M.F., Carver C.S. & Bridges M.W. (1994) 
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Appendix 2.5: Participant Information Sheet 
     
Information Sheet 
Study: An investigation of personality factors and beliefs about illness that 
may influence time taken to seek medical advice for cancer symptoms 
 
My name is Lynn Steele and I am a final-year Trainee Clinical Psychologist at the University 
of Glasgow.  As part of my training I am carrying out research looking at how personality 
factors and beliefs about illness may influence the time taken to seek help for cancer 
symptoms.   
 
You are being invited to take part in this study and this leaflet provides information about it.  
If you have any questions please do not hesitate to speak to me.  My contact details are also 
at the end of the leaflet. 
 
What is the purpose of this research? 
The primary purpose of this research is to examine whether the time taken to seek medical 
advice, by presenting with self-detected symptoms of cancer, is associated with particular 
personality factors and beliefs about illness.  An understanding of the factors that may 
influence the time taken to seek help is of considerable importance in the treatment of 
cancer.   
 
Why have I been chosen to take part? 
All individuals attending the Beatson West of Scotland Cancer Centre for treatment for 
breast cancer or colorectal cancer are being invited to take part in this study. 
 
Do I have to take part? 
No.  Your participation in this study is entirely voluntary and it is up to you to decide whether 
or not you would like to take part.  If you do decide to take part you are free to withdraw at 
any time without giving a reason.  Your decision to withdraw, or not to take part, will not 
affect your on-going care in any way. 
 
What will happen if I agree to take part? 
If you do agree to take part you will be asked to complete a consent form.  I will then meet 
with you to complete some short questionnaires that assess different aspects of personality, 
your beliefs about cancer and your general wellbeing.  You will also be asked to take part in 
an interview with me to recall the time points when you made the decisions that led you to 
seek professional advice about your symptoms.  The interview and questionnaires should 
take no longer than 60 minutes.  I would intend to hold the interview when you are attending 
for routine appointments at the Beatson Centre. 
 
With your consent I will also access your medical notes for information relating to the stage 
of your cancer at diagnosis. 
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Are there risks or benefits to taking part? 
You will not be asked to take any medication or take part in any medical procedures.  You 
will be asked to recall your symptoms and the decisions that led to you seeking professional 
advice.  You will also be asked about your beliefs about illness and cancer.  It is possible 
that these questions may arouse emotional reactions, or indicate that you are having 
difficulty coping with aspects of your diagnosis or treatment.  If so, and you agree that 
you may benefit from professional psychological support, then such support can be 
organised for you. 
    
The results of this study could inform the development of public education programmes and 
materials on common cancer symptoms to encourage individuals to present early.  It could 
also lead to further studies to help health professionals to provide targeted interventions 
aimed at promoting appropriate help-seeking behaviour to ensure we provide the best care.  
These developments could result in a reduction in the time taken to seek help and in turn 
improve prognosis. 
 
Will my taking part in the study be kept private? 
Your identity and personal information will be completely confidential and known only to the 
research team.  The information obtained will remain confidential and stored within a locked 
filing cabinet.  The information is held in accordance with the Data Protection Act, which 
means that we keep it safely and cannot reveal it to other people without your permission.  
Any information that is reported in summarising the findings of the study will have all 
identifiable information removed and will only include general findings.  If you decide to 
withdraw from the study, all personal information collected before that point will either be 
kept with your consent or destroyed if that is what you would prefer. 
 
What will happen to the results of the study? 
It is intended that the results will be published in a journal that specialises in research in 
psychology and oncology.  You can obtain a copy of the publication by contacting me. 
 
If I had a complaint about any aspect of the study to whom should I address it? 
If you are unhappy about any aspect of the study and wish to make a complaint, you can 
contact me (contact details below) or Anne Snape, Complaints Department, Glasgow Royal 
Infirmary, 84 Castle Street, Glasgow, G4 0SF.  Telephone: 0141 2115556. 
 
 
Thank you very much for taking the time to read this leaflet.  Please ask any questions 
you may have. 
 
For Further Information Please Contact:  
Lynn Steele, Trainee Clinical Psychologist, Department of Psychological Medicine, 
Gartnavel Royal Hospital (Tel: 0141 301 7379, Email: lynnsteele@nhs.net) 
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Appendix 2.6: Participant Consent Form  
 
  
 
Centre Number: 1 
Study Number:   GN09ON661 
Patient Identification Number for this trial:  
 
CONSENT FORM 
 
Title of Project: An investigation of personality factors and beliefs about illness 
that may influence time taken to seek help for cancer symptoms 
  
Name of Researcher: Lynn Steele, Trainee Clinical Psychologist 
Please initial box  
1. I confirm that I have read and understand the information sheet dated  
22/01/10 (Version 2) for the above study.  I have had the opportunity  
to consider the information, ask questions and have had these  
answered satisfactorily.  
 
2.  I understand that my participation is voluntary and that I am free to  
withdraw at any time without giving any reason, and without my medical 
care or legal rights being affected.  
 
3. I understand that sections of my medical notes (with regard to stage of the 
tumour at diagnosis) may be accessed as part of this study.  I understand 
that only clinicians involved in the study will have access to these.  I give 
my permission for the research team to have access to my records. 
 
4.  I agree to take part in the above study.  
 
 
________________________  ________________  __________________________  
Name of Patient     Date    Signature  
 
 
 
________________________  ________________  __________________________  
Name of Person     Date    Signature  
taking consent  
 
 
Version 2   22/01/2010
 
 
 
 
Lynn Steele 
Trainee Clinical Psychologist 
Department of Psychological Medicine 
Gartnavel Royal Hospital 
1055 Great Western Road 
Glasgow  
G12 0XH 
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Appendix 2.7: Recording Sheet for Estimation of Symptom and Action Appraisal 
   Participant: _____      Date: ___________ 
Overview of Time Taken To Seek Help 
 
1. First became aware of symptom(s):  ___/___/____ 
Decided symptom(s) may be serious:  ___/___/____       Symptom Appraisal:  _____ days 
2. First decided to seek medical help: ___/___/____             Illness Delay:           _____ days 
3. Arranged an appointment:  ___/___/____                          Behavioural Delay: _____ days 
             Action Appraisal:        _____ days 
 
